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1Chapter 1 Introduction 
Chapter 1 Introduction 
 
Lab-on-a-chip (LOC) is a term for devices that integrate multiple laboratory functions 
on a single chip of only millimeters to a few square centimeters in size and that are 
capable of handling extremely small fluid volumes down to less than pico liters [1]. 
Miniaturization of chemical analysis systems using microchips is an emerging new 
technology. In order to achieve widespread applications of those systems other 
materials (polymers) than silicon are required as the basis of the chips. Currently, 
glass is frequently used as a substrate material due to its favorable electrical and 
optical properties and its ease of structuring by wet chemical etching or powder 
blasting techniques. 
Microfluidic devices have been applied to electrophoretic separations for a variety of 
biochemical and chemical analysis [2-8]. Microchip capillary electrophoresis (MCE) 
is often regarded as a higher miniaturized version of capillary electrophoresis (CE) 
and a lot of applications can easily be transferred from classical CE to the microchip 
format. 
This thesis is divided into two main projects. The following two sections briefly 
discuss the motivations of each project.     
    
1.1 Surface modification project 
 
In order to obtain the desired microstructures in glass, generally a fabrication 
technique based on photolithography is used [9]. Its main disadvantages are the health 
hazards involved with hydrogen fluoride (HF) and the clean room facilities required 
for the photolithographic process, leading to relatively high fabrication costs [10]. 
A cheap and simple process to obtain microstructures in glass was developed in the 
last decade which is known as the “powder blasting” process [11]. The main 
drawback of powder-blasted chips in comparison to hydrogen fluoride (HF)-etched 
fluidic channels is the higher roughness of the channel surface, which, in general is at 
least a few µm for powder blasting and below 100 nm for HF-etching [10]. It was also 
found that the resolution in electrophoretic separation obtained in powder-blasted (pb) 
devices is lower compared to wet chemical etched (wc) chips, which is attributed to 
the much higher surface roughness inducing band broadening [10]. 
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Surface modification is of great importance in chip-based microfluidic devices 
especially in highly miniaturized and integrated systems due to the high surface area-
to-volume ratio [12]. Motivations for surface manipulation are similar to those for 
classical capillary electrophoresis. However, surface modification appears to be even 
more important in microchip capillary electrophoresis for the following reasons: 
(i) Control of the electroosmotic flow (EOF): Stabilization of the electroosmotic flow 
is required in MCE because most of the injection processes such as pinched and gated 
injections rely on the reproducibility of the EOF. Furthermore, stabilization of EOF is 
not only important in order to improve the precision of migration times but also 
necessary for a robust injection process with predefined potentials avoiding back 
leakage of the sample and ensuring injection of a reproducible sample plug. 
(ii) Reduction of analyte-wall interaction: Application of appropriate surface coatings 
reduces the analyte-wall interaction, elevates separation efficiency and enhances 
resolution.  
 
This project focuses on improving the resolution obtained using powder blasted (pb) 
chips. Coating materials such as polyvinyl alcohol (PVA) and 
hydroxypropylmethylcellulose (HPMC) are used to cover the channel walls of the 
chips. These coated pb-chips are utilized in a chip electrophoresis. The obtained data 
are then compared to those based on classical wet chemical etched (wc) chips. 
 
1.2 Therapeutic and abuse drugs analysis project 
 
Drug analysis is undertaken during various phases of pharmaceutical development 
such as formulation, stability studies, toxicological and pharmacological testing [13-
16]. In hospitals, drug analysis is performed on patients’ samples in support of clinical 
trials (bioavailability and pharmacokinetic studies), in monitoring therapeutic drugs 
and drugs of abuse [17-20]. All these investigations require reliable and validated 
analytical methods in order to measure drugs in complex media such as formulations 
and biological fluids. 
For drug analysis, a variety of analytical techniques have been developed involving 
immunoassays [21, 22], spectrophotometry [23, 24], thin-layer chromatography 
(TLC) [25], gas chromatography (GC) [26, 27] and high performance liquid 
chromatography (HPLC) [28–42]. Furthermore, 42 references are found in literature 
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[43] describing some methods for doping control analysis. Most of these methods are 
based on chromatographic techniques [44-51]. These methods, however, require large 
amounts of analytes, are time consuming, use bulky instrumentation and generate 
large quantities of organic waste. Capillary electrophoresis (CE) has also been used as 
an alternative separation method for the analysis of pharmaceutical compounds [52 – 
58]. More recently, considerable interest has been directed to the use of MCE [59] due 
to the fact that MCE has the potential to achieve very rapid analysis (typically 
seconds), easy integration of multiple analytical steps and parallel operation [60-68]. 
For these reasons, MCE would speed up quality control of drugs and thus would 
shorten the time of a drug to enter the market remarkably. 
 
This project focuses on the development and validation of fast methods based on 
MCE to detect some drugs of abuse such as central nervous system stimulant drugs 
and diuretics, which are prohibited by the International Olympic Committee [69], in 
pharmaceutical formulations and human urine. The linearity, reproducibility and 
applicability of those methods are evaluated. Such methods can be used in clinical 
toxicology, therapeutic drug monitoring, forensic science and doping control. 
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Chapter 2 Theoretical background  
 
2.1 History of capillary electrophoresis 
 
The history of the development of capillary electrophoresis (CE) started at 1879 when 
Helmholtz applied an electric field to the ends of a horizontal glass plate. Afterwards, he 
observed a very important phenomenon, which led to the principle of capillary 
electrophoresis, where the bulk liquid flows towards the negative electrode. Based on this 
observation, he could conclude that the plate wall acquired a negative charge while the 
solvent close to the wall surface was positively charged. A second scientist who described 
a similar phenomenon is called Lodge [70]. He also observed the migration of H+ in a 
tube of phenolphthaline in the presence of an electric field. After that Kohlrausch [71] 
described that the passage of an electric current through a uniform electrolyte solution 
does not provide concentration changes in the system. In 1932, Tiselius explained the 
moving boundary method for the electrophoresis of proteins in a U-shaped tube [72]. In 
1937, he introduced a new way of studying proteins and used electrophoretic methods to 
separate the chemically similar proteins of blood serum, an achievement that was 
especially cited in the Nobel award. Therefore he was awarded the Nobel Prize for 
chemistry in 1948.  
In 1967, Hjerten described zone electrophoresis in free solution [73]. He described two 
methods of the problem of eliminating convection in free solution. One of these methods 
is based on rotation (40 rpm) of the horizontal capillary around its long axis while the 
other is based on the use of a stationary capillary with a narrow bore (the latter method is 
now called high-performance capillary electrophoresis). Hjerten’s work mainly focused 
on the first method. At that time (1967) no UV detectors were available that would be 
sensitive enough to detect zones in a tube with a diameter below 1 mm. Hjerten was the 
first to describe the coating technique of the capillaries and the advantages of coated 
capillaries for improving the separation. He also explained the effect of sample 
conductivity on the separation of metal ions, nucleotides, proteins, nucleic acids, DNA, 
purine and pyrimidine bases. In his 1967 publication, Hjerten successfully demonstrated 
the application of free zone electrophoresis ensuring a theoretical understanding of the 
CZE process and expected that CE could become an alternative technique for different 
applications. There is another successful demonstration for capillary zone electrophoresis 
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(CZE) explained by Virtanen [74, 75] who used glass capillaries as separation columns 
with an internal diameter (i.d.) of 0.2-0.5 mm and a column length of 50-100 cm. The 
very important evaluation of concentration distribution in zone electrophoresis was 
explained by Mikkers et al. [76, 77], who demonstrated that rapid and highly efficient 
separations could be obtained in the absence of diffusional broadening. As a result, he 
could confirm the theoretical predictions about separation efficiency which was 
demonstrated by Giddings [78]. 
Jorgenson and Lukacs [79-81] described a very important explanation which led to the 
initial demonstration of the power of modern capillary electrophoresis. They described 
that a high separation efficiency with high-field strength in narrow capillaries (less than 
100 µm i.d.) was obtained. They demonstrated also a brief discussion of the theory of 
dispersion in CE [79]. Since that time CE techniques have been growing fast, and a 
commercial CE instrument became available at the end of the 1980s. Currently, CE is 
gaining popularity as an alternative analytical tool for some routine analytical 
applications. 
 
2.2 Basic principles of capillary electrophoresis  
 
In high-performance capillary electrophoresis (HPCE), separation is performed in narrow-
bore capillaries, typically of 10-100 µm inner diameters (i.d.). The length of the capillary 
differs by different applications, but it is normally in the range of 40-100 cm. Fused-silica 
capillaries, typically used in CE, are externally coated with polyimide (Figure 2.1) which 
gives flexibility to the capillary that would otherwise be very fragile. The small bore 
allows easy control of temperature which improves separation efficiencies. Other types of 
capillaries such as Teflon and polypropylene capillaries have also been used for some 
applications. In a CE system, the ends of the capillary are connected to electrodes, which 
are connected to a high voltage power supply. The capillary ends are placed into buffer 
reservoirs, and the capillary is filled with a buffer identical to that in the reservoirs as 
shown in Figure 2.2. The sample is introduced into the capillary by replacing one of the 
buffer reservoirs with a sample reservoir (usually at the anode end); the sample may be 
injected either electrokinetically or hydrodynamically. After the buffer reservoir is 
replaced, the electric field is applied and the separation is performed. Either on-column or 
end-column optical detection can be made at the cathode end of the capillary. 
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The time interval between the beginning of the separation and the passage of the analyte 
zone through the detection point (migration time, tmig , s) is used for identification of the 
sample components. The information in observed migration times can be made more 
universally comparable by a conversion to observed migration rates or migration velocity 
(νobs, cm/s) according to equation 2.1: 
 
 obs
m
l
t
ν =                                                                                           (2.1) 
 
where l [cm] is the length of the capillary between the point of sample introduction and 
detection. The calculation of migration velocity allows a comparison of migration 
behavior between capillaries of different lengths. To compare migration data of different 
capillary lengths and at different applied separation potentials, it is necessary to calculate 
the observed electrophoretic mobility (µobs, cm2 v-1 s-1): 
 
 
obs
obs E
νµ =                                                                                                                  (2.2) 
 
E [V/cm] is the applied electric field. 
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                       Figure 2.1: Cross-sectional view of a fused silica capillary [82]. 
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Figure 2.2: Schematic diagram of a classical capillary electrophoresis system [83]. 
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2.2.1 Electrical double layer  
 
The formation and structure of the electrical double layer is important in CE because any 
change in this layer will change the electrophoretic behavior of ions. The structure of the 
electrical double layer is shown in Figure 2.3. When the silica surface is negatively 
charged, counterions tend to adsorb on it by electrostatic attraction which balances the 
surface negative charge. According to Stern’s model (Figure 2.3A), a rigid double layer of 
adsorbed ions (Stern layer) is in equilibrium with an outer diffuse layer allowing diffusion 
of ions by thermal motion. 
This double layer system provides an electric potential ψ at the interface between silica 
surface and electrolyte solution. Within the rigid double layer the potential decreases 
linearly with the distance from the surface and becomes zero in the diffuse layer as shown 
in Figure 2.3B. The potential at the shear plane is known as the zeta potential (ζ-
potential). 
A layer of water, about a molecule in thickness, is probably bound to the charged surface, 
mainly by charge-dipole interaction. The usual location of the surface of shear is therefore 
just outside the Stern layer and the ζ-potential is generally smaller in magnitude than ψd. 
The electrokinetic potential, which can influence ion migration in CE, is determined by 
the properties of the electrical double layer [84-86]. The zeta potential is proportional to 
the surface charge density and the thickness of the double layer. This potential can be 
influenced by many parameters such as the pH of the separation medium, ionic strength, 
charge and nature of counterions, surface active agents, and organic solvents [86].     
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Figure 2.3: Schematic diagram of the electrical double layer. δ and ζ are the thickness of 
the diffuse layer and zeta potential, respectively [87]. 
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2.2.2 Electroosmosis 
 
Electrosmosis is defined as the movement of liquid relative to an immobile charged 
surface in the presence of an electric field. The fused silica capillaries that are typically 
used for separations have ionizable silanol groups in contact with the buffer which fills 
the capillary. 
The negatively-charged wall attracts positively-charged ions from the buffer, creating an 
electrical double layer. When a voltage is applied across the capillary, cations in the 
diffuse portion of the double layer migrate in the direction of the cathode, carrying water 
with them. This results in a net flow of buffer solution in the direction of the negative 
electrode. Such a phenomenon is called electroosmotic flow (EOF). 
The electroosmotic flow (EOF) has a plug form profile as shown in Figure 2.4. The plug 
form of EOF can result in less peak broadening and higher separation efficiency 
compared to HPLC separation [88]. The magnitude of the electroosmotic mobility can be 
calculated by the use of the Smoluchovski equation [89]:                                         
                                                                                                                                         
 -
4eo
εζµ πη=                                                                                                          (2.3)                         
 
 
Where η is the medium viscosity (Poise), ε is the dielectric constant (Fm-1), and ζ is the 
zeta potential (V). The EOF can be measured by the injection of a neutral compound 
(neutral marker). 
 
2.2.3 Electrophoresis 
 
Electrophoresis is defined as the migration of charged species in an electrolyte solution 
under the influence of an electric field. Ionic solutes are separated based on differences in 
charge, size and shape. When a charged particle is placed in an electric field it 
experiences a force which is proportional to its effective charge q and the electric field 
strength. The transitional movement of the particle is opposed by a viscous drag force 
which is proportional to particle velocity, hydrodynamic radius r and medium viscosity. 
When the two forces are counterbalanced the particle moves with a steady state velocity. 
Electrophoretic mobility of an ion is defined by: 
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6ep
q
r
µ πη=                                                                                                                 (2.4) 
                                                                                                                  
This equation is suited only for spherical particles under the assumption that the velocity 
of the liquid, relative to the particle, vanishes at the particle surface [90, 91]. From 
equation 2.4 we can see that differences in electrophoretic mobility will be caused by 
difference in the charge-to-size ratio of ions. In an applied electric field, cations move 
towards the cathode (negative electrode) while anions move towards the anode (positive 
electrode). Different ions and solutes have different electrophoretic mobilities; therefore 
they also have different migration velocities at the same electric field. This could be 
explained as in a normal situation at pH>3, the capillary surfaces are negatively charged, 
and thus the EOF is cathodal. When cations move in the same direction as the EOF 
(towards cathode), their apparent mobility (µobs) is larger than their electrophoretic 
mobility (µep<µobs). If anions move in the opposite direction to the EOF, their apparent 
mobility is smaller than their electrophoretic mobility (µep>µobs), as shown in Figure 
2.4A. The corresponding migration order in an electropherogram is shown in Figure 2.4B.   
 
2.2.4 Flow profile in CE  
 
Due to the EOF in CE having a flat flow profile (Figure 2.5A), the peak efficiency in CE 
is much better than in HPLC. This profile is caused by EOF’s driving force being 
uniformly distributed around the wall of the capillary. In HPLC, the frictional forces at 
the column walls cause a pressure drop across the column, yielding a parabolic or laminar 
flow profile, as shown in Figure 2.5B.  
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Figure 2.4: (A) Mobility of ions in an applied field where length of arrows represents 
velocity vectors. (B) Migration order of the analyses [92]. 
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Figure 2.5: Hypothetical flow profiles and corresponding peak forms in case of (A) 
electrokinetic flow and (B) hydrodynamic flow [93]. 
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2.2.5 Efficiency  
 
In separation science, two related concepts for measuring the efficiency of a separation 
are widely used namely the plate height (H) and the plate number (N). The width of the 
analyte zone can be expressed in terms of the plate height [94]: 
 
2
H
L
σ=                                                                                                                         (2.5) 
 
where σ2 is the variance of the zone and L is the effective separation distance to the 
detector. In any experiment, the zone broadening of a solute should be kept as small as 
possible, which means that the variance of a zone (σ) should be kept at a minimum. Low 
values of H are thus favorable and are in the µm range for high efficiency separations. 
An alternative, commonly employed term in electrophoresis is the plate number (N): 
 
2
2
L LN
H σ= =                                                                                                            (2.6) 
 
The plate number for a Gaussian curve (Figure 2.6) can be obtained at half of the height 
or at the baseline of the peak by use of the following formula: 
 
2
. itN f
w
⎛ ⎞= ⎜ ⎟⎝ ⎠                                                                                                              (2.7) 
 
where w is the width of the peak at half of the height or at the baseline, ti is the migration 
time and the factor f is 5.54 when w is at half of the height and 16 when the width of the 
peak at the baseline is used. The values of the plate numbers are commonly in the range 
of 1×105 to 5×105 m-1 [95].  
The efficiency of separation is only limited by diffusion and is proportional to the strength 
of the electric field as shown in the following equation: 
 
2 m
VN
D
µ=                                                                                                            (2.8)                       
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)
Where µ is the apparent mobility in the separation medium and Dm is the diffusion 
coefficient of the analyte. 
 
2.2.6 Resolution  
 
The resolution (Rs) is a quantitative measure of the degree of separation of two species 
and is defined as [94]: 
 
( 1 2
2 mig
s
t
R
w w
⋅ ∆= +                                                                                                          (2.9) 
or 
( )1(1/ 2) 2(1/ 2)
0.589 mig
s
t
R
w w
⋅ ∆= +                                                                                                (2.10) 
 
where ∆tmig is the difference between the migration times of the analytes and w1 and w2 
are the widths of the peaks at the baseline; w1(1/2) and w2(1/2) are the peak widths at half of 
the height. Accordingly, to achieve a high resolution ∆t should be large, whereas the zone 
width should be kept at a minimum. Rs is dependent on the number of theoretical plates 
and the relative mobility difference between any two species [96]: 
 
4
app
s
NR
µ
µ
∆= ⋅                                                                                                          (2.11) 
 
where ∆µapp is the difference in apparent mobilities of two solutes (for instance, 
enantiomers) and    is their average mobility. The Rs is made up of both selectivity (∆µ 
/µapp) and efficiency (N) terms. The selectivity term is determined by the properties of the 
analytes and the buffer, whereas the efficiency term is determined by the properties of the 
buffer and the instrument. 
µ
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Figure 2.6: Measurements used to calculate efficiency and resolution from an 
electropherogram. trB: retention time of peak B, trA: retention time of peak A, ∆tr: 
difference in retention of peaks A and B, h: height of peaks, ½h: half height of peaks, w: 
width of peak at base, w½: width of peak at half of height [97]. 
 
 
2.3 Factors affecting peak resolution in CE 
 
2.3.1 Electrodispersion 
 
The description of electrodispersion is given by Kohlrausch’s regulating function [71]. 
Differences in sample zone and running buffer conductivity have three major effects. 
When the solute zone has a higher mobility (i.e. higher conductivity) than the running 
buffer, the leading edge of the solute zone will be diffused and the trailing edge becomes 
sharp (Figure 2.7A). Conversely, when the solute zone has a lower mobility than the 
running buffer, the leading edge will be sharp and the trailing edge diffuses (Figure 2.7C). 
When the conductivities are equivalent, no such peak distortion will occur (Figure 2.7B). 
This situation is reversed when anions are analyzed instead of cations. Neutral species are 
unaffected by this conductivity difference [75]. 
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Figure 2.7:  Electrodispersion due to mismatched sample and buffer conductivities [93]. 
 
 
2.3.2 Joule heating   
 
When a current passes along an electrolyte solution inside the capillary, electrical energy 
is partially converted into Joule heating due to frictional collision between mobile ions 
and buffer molecules. As a result of heat generation the temperature increases within the 
capillary. The control of the buffer temperature in CE is important for the success of 
separation. The elevation of temperature inside capillary can lead to problems with 
reproducible sample injection [98], sample stability [99-101], band broadening [102-105] 
and quantification [77, 106]. Also, heat generation can lead to undesirable effects such as 
bubble formation and decreases in conductivity in the capillary. 
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2.3.3 Solute-capillary wall interactions 
  
The solute-capillary wall interactions phenomena are problematic in CE in term of 
efficiency. The primary causes of adsorption to the fused silica walls are ionic 
interactions between cationic solutes and the negatively charged wall. This is due to the 
fact that fused silica capillaries acquire a negative charge at pH > 3.  
As shown by Schure and Lenhoff [107] for the separation of small molecules, where 
diffusive transport is high, smaller diameter capillaries are clearly more favorable in 
limiting the potential loss of resolution due to wall adsorption. Various salts, zwitterions 
and surfactants have been used in buffers to compete with solutes (mostly proteins) for 
adsorption sites and to minimize adsorption [108-110]. The solute-wall interactions can 
also be affected by dynamic or permanent coating of the capillary wall [111-114].  
 
2.3.4 Running buffer   
 
The selection of the running buffer is a critical factor in CE because its composition 
determines the migration behavior of the analytes. A buffer which provides a constant pH 
is favorable in CE. It enhances the sensitivity of both electrophoretic mobility of the 
charged species (µe) and EOF (µEOF). A wide variety of buffer systems have been used to 
effect the required separations. A selection of common buffers is given in Table 2.1.  
Some general guidelines can be given for the selection of buffers in CE. Phosphate buffer 
is widely used in CE because it can be applied in a large pH-range and it also absorbs at a 
wavelength below 260 nm. For buffers in the basic pH range, TRIS, Tricine and borate 
are acceptable electrolytes. The advantage of zwitterionic buffers such as MES, PIPES, 
HEPES and CHES is their low conductivity. This results in a reduction of Joule heating, 
allowing a higher buffer concentration to be used. This is sometimes useful for 
minimizing solute-wall interactions, the undesirable effects of electrodispersion and the 
EOF. 
In addition to the type of buffer, its concentration is another principal variable in CE. 
Theoretically, buffers with high ionic strengths are preferable to minimize solute-capillary 
wall interactions. On the other hand, highly concentrated buffers have greater 
conductivity and hence generate more heat; in this case a thermostating/cooling system is 
necessary. 
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Table 2.1: List of commonly used buffers with their characteristics [115]. 
  
Buffer pKa pH-range 
Mobility 
(10-5 cm2 V-1 s-1)
Minimum useful   
 λ (nm) 
Phosphate 2.12, 7.21, 
12.30 
1.14-3.14 
6.20-8.20 
 195 
Citrate 3.06, 5.40 3.06-5.40  260 
Acetate 4.75 3.76-5.76 -42.4 220 
Formate 3.75 2.75-5.75 -56.6 220 
MES 6.13 5.15-7.15 -26.8 230 
PIPES 6.80 5.80-7.80  215 
HEPES 7.51 6.55-8.55 21.8 230 
Tricine 8.05 7.15-9.15  230 
TRIS 8.30 7.30-9.30  220 
Borate 9.14, 12.74, 
13.80 
8.14-10-14  180 
CHES 9.50 9.50  190 
 
 
2.3.5 Applied voltage  
 
The optimization of the applied voltage (V) in CE is given by the following basic 
equation [116] for peak resolution (Rs): 
( ) 1/ 21
4 2
av EOF
s
av EOF
V
R
D
µ µ µ
µ µ
+⎡ ⎤ ⎡ ⎤∆= ⎢ ⎥ ⎢ +⎣ ⎦⎣ ⎦ ⎥                                                                             (2.12) 
According to equation 2.12, the peak resolution (Rs) is proportional to the square root of 
the applied voltage. In order to double the resolution the applied voltage should be 
quadrupled. This can lead to heat generation inside the capillary which limits the value of 
an increase in voltage for achieving a high resolution in CE. For technical reasons most of 
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CE instruments operate under a high voltage limit of 30 kV. Although an increase of 
voltage can improve the peak resolution, attention should be taken to not arrive of the 
voltage limit (30 kV). A high voltage limit leads to an undesirable effect such as bubble 
formation. 
 
2.3.6 Injection plug length 
 
During injection it is important to minimize the sample plug length to get high peak 
efficiency. A practical limit of the injection length is less than 1 or 2 % of the total 
capillary length [117]. In CE, a solution of analytes is used in a micro- and nanoliter scale 
For example the total volume of a 1 m long capillary of 50 µm i.d. is 2 µl. For this reason, 
even a very small additional volume within the system can lead to strong disturbance of 
the equilibrium and can cause additional band broadening. Therefore the injected sample 
plugs should not be too long for a particular separation system. If the sample plug is 
longer than the dispersion caused by diffusion, the efficiency and resolution will be 
affected. According to this statement, the plug length for high molecular weight analytes 
is essentially shorter. 
The contribution of the sample volume ( ) to the total peak dispersion can be expressed 
as [118]: 
2
sσ
 
( )
2
2
412 /s R c
S
d r
σ υ π=                                                                                                  (2.13) 
 
where S is the sample volume, υR is the linear velocity of the sample injection and dc is 
the inner diameter of the cylindrical capillary. 
 
2.4 Modes of capillary electrophoresis 
 
Capillary electrophoresis is used in different applications such as separation of peptides, 
proteins, oligonucleotides, metal ions and inorganic ions as well as in the analysis of 
pharmaceuticals and the monitoring of water quality [119-125]. Although the basic 
principle of CE involves the separation of molecules based on their charge to mass ratio, 
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there are some modifications to this procedure obtained from existing well-established 
techniques. This alteration allows the separation of non-charged molecules or even optical 
isomers. The following sections will outline some of the currently used CE techniques. 
 
2.4.1 Capillary zone electrophoresis (CZE) 
 
Capillary zone electrophoresis (CZE) is the most widely used type of CE because of its 
simplicity. The separation mechanism of CZE is based on differences in the charge-to-
mass ratio of the analytes, this leads to different electrophoretic mobilities of the analytes 
in free solution under the effect of an electric field. 
In CZE the apparent mobility (µapp) of an ion is the sum of the analytes’s inherent 
electrophoretic mobility (µe) and the electroosmotic flow (µEOF) of the capillary. 
 
app e EOFµ µ µ= +                                                                                                   (2.14) 
                  
2.4.2 Micellar electrokinetic capillary chromatography (MEKC) 
 
One limitation of the above described CZE-technique is that only the charged molecules can 
be separated. Neutral analytes have no electrophoretic mobility and therefore all of those are 
moving with the EOF. As a result, no separation will occur and all molecules will arrive at 
the detector at the same time. For this reason, Terabe et al. [126] described MEKC for the 
separation of neutral analytes. Terabe described that an ionic surfactant micelle is used as a 
pseudostationary phase that corresponds to the stationary phase in liquid chromatography 
(LC). A portion of the sample molecules, introduced in the micellar solution, is incorporated 
into the micelle. The analyte acquires an apparent electrophoretic mobility by interacting 
with the micelle and a distribution equilibrium is established between the micelle and the 
surrounding aqueous phase. The analyte that is not incorporated into the micelle migrates at 
the same velocity of the EOF. The separation of molecules is based on their distribution 
coefficient between the micellar and the non-micellar (aqueous) phase. Sodium dodecyl 
sulfate (SDS) is widely used as an anionic surfactant in MEKC because it is easily available 
in a sufficiently pure form, has good water solubility and is able to solve non-polar 
molecules [127]. The presence of an anionic micelle based on SDS means that cationic 
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molecules will associate with the micellar phase while anions will be repelled but migrate 
to the detector window with the EOF. The separation principle of MEKC with SDS 
micelles is shown in Figure 2.8. 
 
EOF
----------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------
Solute molecule
Surfactant molecule
_+
Electrophoresis of the micelle
 
Figure 2.8: Schematic diagram showing MEKC partitioning of neutrals into/out of 
micelles. The directions of the velocity are given below the capillary [127]. 
 
 
Based on this principle, ephedrine and its diastereoisomer pseudoephedrine are separated 
using SDS in this work (see chapter 4). 
 
2.5 Fluorescence detection in CE 
 
Fluorescence detection has emerged as one of the most sensitive detection modes used in 
CE, especially for trace analysis of derivatized amino acids, peptides and 
oligosaccharides. The high sensitivity of this technique is a result of the low background 
noise and the direct proportionality between excitation power and emission signal 
intensity. For fluorescein, a detection limit of approximately 10-8 M (S/N=2) has been 
obtained for conventional fluorescence detection [128]. Using laser-induced fluorescence 
(LIF) detection, LODs of as low as 10-12 M have been realized for fluorescence 
derivatives of amino acids [129]. A fluorescence detector is comprised of an efficient 
excitation source, a detection cell and an arrangement to detect the fluorescence signal. 
Fluorescence detection in CE is mostly performed on-column by aiming the excitation 
beam at the capillary and collecting the emission on a photo-sensitive device such as a 
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photodiode or photomultiplier tube.  
The Argos 250B (Figure 2.9) is a sensitive fluorescence detector for many applications in 
capillary electrophoresis. For many compounds the Argos 250B allows increasing 
sensitivity in CE down to the 1 ng/mL range. The fluorescent light is totally reflected 
within the capillary in a down-stream direction. This is then diverted by a glass ellipsoid, 
sleeved over the capillary, at the downstream end of the optical window. In order to allow 
emitted light to leave the capillary window at the ellipsoid’s 1st focus, optical contact is 
established by applying a tiny amount of glycerol which is held in the contact area by the 
capillary force. Fluorescence light, which is "trapped" in that way by the ellipsoid, is 
deflected to its 2nd focus and conducted from there to the photomultiplier in the detector 
by the emission light guide. In order to keep the optical path free for the emission light 
guide, the capillary is bent out of the way. This kind of detector is used in this work for 
different applications such as polyaromatic hydrocarbons (PAHs), central nervous system 
stimulant drugs and diuretics. 
 
Light cone
Photomultiplier
Emission light
Flow direction
Excitation light
Fluorescence light
Capillary window
11 mm
0.3/0.5 mm
  
Figure 2.9: Schematic diagram of the Argos system [130]. 
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2.6 Capillary electrophoresis on microchip 
 
The concept of microchip separations is not new. In 1979 [131] the first report of a 
microfabricated gas chromatography column has been published. In 1990 [132] the first 
example of a microfabricated gas chromatography system appeared. A little excitement 
was generated over these early developments, due to the complexity of the operational 
systems and the generally poor performance of the devices. The first work on microchip 
capillary electrophoresis was published in 1992 and demonstrated that a significant 
improvement in speed is obtained by miniaturizing conventional separation methods [133, 
134]. The steadily growing number of publications on MCE each year shows the 
sustained interest and continuing development as shown in Figure 2.10. 
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Figure 2.10: Number of publications in scientific journals containing the keywords         
capillary electrophoresis and microchip in the title or abstract [43, 133, 134]. 
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Capillary electrophoresis on a microchip is an emerging new technology that promises to 
lead the next revolution in chemical analysis. It has the potential to simultaneously assay 
hundreds of samples in a matter of minutes or less. The use of microfabricated analytical 
devices is especially attractive when high speed or high throughput is needed. In recent 
years [135-140], it has become generally accepted that high throughput analytical 
methods are needed in various emerging application fields of life sciences, especially in 
the field of genomics and proteomics. It also strongly applies for pharmaceutical analysis 
due to the growing importance of combinatorial chemistry, parallel synthesis, and high 
throughput screening in drug discovery. Although microchip electrophoresis is one of the 
most successful applications of chip based microfluidics, which is also reflected by the 
introduction of commercial systems, it has only rarely been applied to quantitative 
analysis of pharmaceuticals [141-144]. This is especially true for so-called “real 
samples”, such as commercial formulations. 
Microchip electrophoresis (MCE) could become an attractive alternative to high-
performance liquid chromatography (HPLC) due to its economic properties in terms of 
the low reagent consumption and high speed of analysis. Furthermore chip electrophoresis 
has a great potential for multiplexed separations [67, 68] as well as for complex lab-on-a-
chip systems integrating chemical synthesis and analysis on a single microfluidic device 
[145].  
 
2.6.1 Chip materials and fabrication 
 
Most microchip devices have been fabricated from glass, quartz, silicon, or polymer 
materials [146]. The standard procedure for fabrication of a microchip device involves a 
photolithography process adapted from the micro-electronics industry. More recently, 
powder blasting has shown the simplicity of the production of microchips with a complex 
structure. 
The advantages of using a glass substrate microchip in comparison to a polymer chip are 
summarized as: 
1- Better hydrophilicity 
2- Chemical inertness 
3- Optical clearness 
4- Non-porous 
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5- Suitable for prototyping 
Beside these advantages, the etched glass surface provides high electroosmotic flow 
(EOF), its surface chemistry is well understood, contain many reactive silanol groups and 
many methods of modifying glass surfaces are available. Glass substrates, however, suffer 
from some limitations such as adsorption of analytes to a negatively charged wall, metal 
ion impurities, being fragile and slow fabrication.  
In order to overcome limitations of glass, the development of polymer microfluidic 
devices is an active and growing area of research. Polymer substrates are generally less 
expensive than glass substrates and there are a wider variety of fabrication methods that 
are faster and easier. Fabrication methods of polymers include laser ablation for 
polystyrene, polycarbonate, cellulose acetate, poly (ethylene terephthalate), replica molding 
for PDMS, injection molding and hot embossing imprinting for polymethylmethacrylate 
(PMMA) [147, 148]. However, most polymers are not chemically inert and may dissolve in 
some organic solvents. Most polymers also tend to be hydrophobic, exhibit poor wettability 
and need to be coated as well to minimize surface interactions with proteins. 
 
2.6.1.1 Photolithography and wet chemical etching 
 
Photolithography is a process where a pattern is transferred to a substrate by optical 
means. For microfluidic devices, the pattern is a 2D layout of the channels and reservoirs. 
A chromium/gold film is distributed onto the surface of the substrate. A positive 
photoresist is spin-coated on the chromium surface, and the channel design is transferred 
to the substrate using a photomask and UV exposure of the photoresist [9]. When 
ultraviolet light strikes the photoresist, it weakens the polymer in the portions exposed to 
the light. These portions are washed away during developing and the image of the mask is 
transferred to the photoresist layer. After exposing and developing the photoresist the 
metal films are etched by using KI/I2 for gold and K3Fe(CN)6/NaOH for Cr. The channels 
are then etched into the glass substrate with a HF/HNO3 solution. A summary of the 
process is outlined in Figure 2.11.  
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Figure 2.11: Photolithography process [9]. 
 
2.6.1.2 Powder blasting 
 
Powder blasting is a fast and inexpensive method of making holes, cavities and channels 
for brittle materials such as glass, silicon and ceramics [11]. This micro patterning process 
relies on mechanical erosion of a masked material by a high velocity powder beam 
(Figure 2.12). Powder blasting is a relatively fast process, with erosion rates of 100 
µm/min, which is more than 100 times faster than wet chemical etching. This makes the 
technique especially attractive for fast prototyping.  
Powder blasting has been evaluated to structure microfluidic chips for electrophoresis 
[149-152]. It is shown that such devices can in principal be applied in chip 
electrophoresis. It was, however, found that the resolution in electrophoretic separation 
obtained in powder-blasted (pb) devices is generally lower compared to wet chemical 
etched (wc) chips. This is attributed to the much higher surface roughness of the pb-chip 
wall [153]. 
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Figure 2.12: A schematic diagram of the powder blasting process [11]. 
 
 
2.6.2 Detection in MCE 
 
Although MCE has several advantages with regard to separation performance, size and 
chemical integration, detection is one of the disadvantages in MCE. The small dimensions 
of a microchip result in a small sample volumes that require an extremely sensitive 
detection technique. Therefore development of suitable detection methods providing 
higher sensitivity for a wide variety of analytes is a challenge in MCE. The most 
commonly used detection technique in MCE is fluorescence detection due to its high-
sensitivity and can easily be implemented in the experimental setup. The key to 
ultrasensitive fluorescence detection is the ability to maximize signal while minimizing 
background. 
Currently, LIF detection is a widely utilized mode in microchip devices [154, 155], due to 
its high sensitivity and compatibility with the typical chip dimensions (i.e. the ease of 
focusing a laser beam onto the µm-sized channels). However, these conventional lasers 
are generally expensive, relatively instable and have short lifetimes (3000 h) [156]. 
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Various LIF detection systems based on a HeCd laser (325 nm), argon ion laser (488 nm) 
and frequency quadrupled Nd:YAG laser (266 nm), were developed and have been 
successfully applied in microfluidic devices. 
In the literature, Ramsey’s group [157] reported a detection limit of 1.7 pM rhodamine 6G 
and 8.5 pM rhodamine B in a chip-based system with a LIF detector. Harrison’s group 
developed a series of epifluorescence microscope systems for microchip LIF detection, in 
which LODs are 300 fM for fluorescein [158] and 9 pM for Cy-5 [159]. Recently, 
Schulze et al. [160] described a deep UV fluorescence method for the detection of 
unlabeled basic proteins on a chip based on their native florescence. The use of a lamp-
based system with flexible variable wavelength detection was also reported [161].  
A disadvantage of fluorescence detection is that most of the analytes have to be 
derivatized prior to analysis, which is not only inconvenient and sometimes troublesome. 
If the analyzed compounds exhibit native fluorescence at the excitation wavelength 
troublesome labeling can be avoided. This is described in chapter 4 where diuretic drugs 
exhibited native fluorescence and thereby the labeling process was avoided.  
Most lasers are significantly larger in scale than microchips and not portable or 
disposable, limiting their use in point of care testing applications.    
 
 
2.6.3 Chip layout 
 
An attractive feature in utilizing microfibricated structures is the integration of different 
kinds of fluid manipulation on a single device. The first chip design consisted of 
microchannels with a cross layout geometry. Afterwards the design of microchips 
provided significant development from simple single-channel structures to complicated 
ones. Design rules for many channel geometries and separation length were developed 
using computer-aided design tools. Currently, microchip design allows reaction and 
separations on a single microchip with multiple channels [145]. Different chip layouts are 
shown in Figure 2.13. 
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Figure 2.13: Microchip layouts [162]. 
 
 
2.6.4 Pinched injection 
 
The pinched injection is performed using electrokinetic forces to restrict the sample in the 
loading step. Then the sample is injected as a plug.  Ideally, a short well defined sample 
plug is required to achieve high separation efficiencies as given by equation 2.15: 
2
2
12
inj
inj
Iσ =
                                                                                                          (2.15) 
σinj is the variance due to injection plug length Iinj. 
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Samples are easily introduced into the channels by applying high voltage without the 
necessity to use high-pressure pumps avoiding a laminar flow profile. Pinched injection 
allows the injection of very narrow sample plugs. This is achieved by pinching potentials 
which are applied at the buffer inlet and outlet, inducing buffer flows to the sample outlet 
which is grounded. This prevents sample leakage into the separation channel and band 
broadening during injection. In Figure 2.14, a schematic drawing of the pinched injection 
process and the following separation is shown. The complex fluid handling is performed 
by directed manipulation of the applied voltages at the reservoirs due to electroosmosis 
and electrophoresis [140]. The pinched sample plug is time dependent therefore relative 
long injection times are required for the analytes to fill the intersection (about 15 s). Once 
a stable sample plug is achieved (Figure 2.15), the high voltage is switched to the 
injection mode in which the analytes move under the influence of the EOF to the detector 
end and the separation is performed. 
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Figure 2.14: Schematic drawing of the injection/separation process in MCE applying 
pinched injection [140]. 
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Figure 2.15: Video images of the pinched injection process. 
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3.1 CE instrumentation and capillary 
 
For classical CE measurements in this thesis, a home-build CE instrument is used. 
Untreated fused-silica capillaries 50 µm i.d. × 375 µm o.d. (BGB Analytik Vertrieb, 
Germany) are used for separation. For on-column detection, an Argos 250B 
fluorescence detector (Flux Instruments, Basel, Switzerland) is used. 
 
3.2 MCE-instrumentation 
 
High-voltage source  
 
A programmable bipolar four-channel high-voltage source (type HCV 40M-10000, 
FUG-Elektronik, Rosenheim, Germany) is used [161]. Using this type of power 
supply, the electrical potential (–10 to +10 kV) per channel can be adjusted using a 
manual program mode (see photo 3.1). 
 
Optical and mechanical parts  
 
The schematic drawing of the instrumental setup including the HV-source and the 
optical setup is shown in Figure 3.2. The optical parts consist of an epifluorescence 
microscope (Olympus IX 50) fitted with a video camera (PCO Computer Optics, 
Kehlheim, Germany) for imaging the flows in microchannel [161]. The two standard 
objectives Lucplan FI 10X and 40X are equipped with the microscope setup. The 
latter is used to visualize the fluorescence emission during separation. Fluorescence 
excitation is performed using a 100W mercury lamp which is attached to the 
microscope. For wide range of applications, three different fluorescence excitation 
filter blocks are used. These excitation filters are 330–380, 360-370 and 450–480 nm 
with the corresponding emission filters of 420, >420 and >515 nm and dichroic 
mirrors of 400, 400 and 500 nm, respectively. A photomultiplier tube (PMT) 
(Hamamatsu 7711–03) is attached at the side place of the microscope (see photo 3.1) 
to detect the fluorescent light. An adjustable optical aperture (viewfinder, Till 
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Photonics, Gräfelfing Germany) is installed in front of the PMT which allows to 
restrict the detection area with a rectangular aperture. The viewfinder is equipped with 
various mirrors and filters and with a video camera which enables to visualize the 
fluorescence detection area on a video monitor [161]. 
inverse sHg-Lampe
Monitor
PMT
Video recorder
Fluorescence microscope
4 channel power supply 
Video camera
Power supply for Hg-lamp
 
                                 Figure 3.1: Photo of the MCE-system. 
 
 
The microchips are placed in a chip mount (Figure 3.3A) which is made from Vitronit 
(Vitron, Jena, Germany). The chip mount is made of glass ceramic with very low 
electric conductivity and high mechanical stability [146]. The electrode cover plate 
(Figure 3.3B) is made of Plexiglas with a built-in IR-high pass filter which contains 
four chemically inert pt electrodes. These electrodes are designed to fit the microchip 
layout (simple cross layout). This setup allows a safe operation protecting the 
environment from the high voltages and the UV-irradiation [161]. 
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Figure 3.2: Instrumental setup of a modular MCE [161]. 
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Figure 3.3: (A) Chip mount, (B) electrode cover plate [162]. 
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3.3 MCE-LIF coupling 
 
The flexibility of the experimental set up allows to use different light sources for 
fluorescence excitation which is a real benefit for the development of various 
applications [141]. The following sections will describe some types of lasers used in 
this thesis.   
 
Frequency quadrupled pulsed laser operating at 266 nm  
 
To enable microchip electrophoresis with deep UV-LIF detection, the standard 
objective in the microscope setup (Figure 3.4) is replaced by a filter cubus holding the 
fused silica objective (Partec GmbH Münster, Germany). A fiber coupled pulsed, 
frequency quadrupled Nd:YAG laser (type FQSS266-Q; 4 mW) purchased from 
Crystal GmbH (Berlin, Germany) is used as excitation light source [160].  
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Figure 3.4: MCE-laser coupling [160]. 
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HeCd laser operating at 325 nm 
 
For coupling a HeCd laser operating at 325 nm with an emission filter >350 nm 
(Series 74, Model No. 3074-EOS-A01, 20 mW, Laser 2000, Wessling, Germany), a 
similar setup as in the pervious section is used. The dichroic mirror reflects light with 
wavelength of <335 nm, whereas light of >340 nm is transmitted. 
 
Argon-ion laser operating at 488 nm 
 
For coupling of the argon-ion laser operating at 488 nm with an emission filter at 520 
nm (Series N129239Q, Model No. 163-D1241, 25 mW, Spectra-Physics, USA), an 
adapted filter cubus holding the fused silica objective is developed. 
 
3.4 Microchip 
 
All microchips used in this thesis have a simple cross layout as shown in Figure 3.5. 
Two types of microchips are used in this thesis, a wet chemical etched chip (wc) and a 
powder blasted chip (pb).  
  
Wet chemical etched microchips 
 
The microchips made from low-fluorescent borofloat glass (BF) are purchased from 
Micralyne (Edmonton, Canada) with outer dimensions of 90 × 15 × 2.2, a separation 
channel length of 85 mm and an injection channel length of 8 mm. At the end of each 
channel there is a 1.1 mm deep hole with 2 mm in diameter. These holes are labeled 
as buffer inlet (BI), buffer outlet (BO), sample inlet (SI) and sample outlet (SO). High 
grade fused-silica (FS) microchips (channels were 20 µm deep and 50 µm wide at the 
top as shown in Figure 3.5) are also used. 
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Figure 3.5: Simple cross microchip layout and channel dimensions [163]. 
 
 
Powder blasted microchips 
 
Powder blasted (pb) glass chips are purchased from Micronit (Enschede, The 
Netherlands). Microchannels have been blasted [1] in borofloat substrates with 9 µm 
aluminum-oxide powder. One substrate has been blasted with 5.6 bar compressed air, 
the other with 4.0 bar. The blasted channels are 38 µm (5.6 bar) or 43 µm (4.0 bar) 
deep and 100 µm wide at the top. 
 
3.5 Chip handling and storage 
 
At the beginning, 1 M NaOH is used as an etching solution to remove the undesirable 
adsorbed materials in uncoated chips. This solution is left inside the microchannel for 
1 h to ensure a complete etching process. After etching, the holes are emptied by 
applying a vacuum at the buffer outlet. Afterwards, the channel is rinsed using 
deionized water for 2 min followed by emptying the channel. Finally, the 
microchannel is rinsed with the running buffer for 2 min. For cleaning and storage, 
the chip is filled with 96% H2SO4/30% H2O2 (3:1) overnight. PVA-coated chips are 
rinsed with water only for 2 min and stored dry. 
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3.6 Chip coating  
 
Before coating, the chips are etched with 1 M NaOH for 1 h followed by a rinsing 
step with deionized water for 1 min. Afterwards a 1% w/w aqueous PVA coating 
solution is slowly injected through the four holes using a 50 µL syringe [164]. After 
complete filling the channels are emptied by applying gas pressure (N2, 5 bar). Then, 
the chip is inserted into a metallic connection device and connected with a FS 
capillary as shown in Figure 3.6. The channels are dried under a 5 bar nitrogen flow 
for 15 min. To immobilize the PVA layer on the channel wall, the chip in the metallic 
device is placed in a GC oven and heated to 70 oC with 15 oC/min for 1 h. Finally the 
chip is heated to 160 oC with 15 oC/min for 10 min while the channels are flushed 
with 1.5 bar nitrogen flow. Then, the chip is allowed to cool down to room 
temperature inside the oven. 
 
FS-capillaries
Gas pressure
Plexiglas cover plate
microchip
Plexiglas chip mount
 
 
Figure 3.6: Schematic drawing of the coating device [164]. 
 
 
3.7 Derivatization and solutions 
 
Derivatization of amines with Alexa Flour 350 
 
To prepare the Alexa flour 350 (AF350)-amine stock solutions, 100 µL of an amine 
solution (0.5-1 µM in ACN or methanol) is mixed with 20 µL of a AF350-solution (1 
mg/mL in dried DMSO) and 50 µL borate buffer (20 mM, pH 8.5). The reaction is carried 
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out for 4 h in the dark. All stock solutions are stored at -20 0C. Scheme 3.1 shows the 
reaction of the AF350 with an amine.  
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Scheme 3.1: Analyte dervitization with Alexa Fluor 350.
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Excitation-emission spectra of AF350 
 
AF350 is optimally excited at 346 nm and exhibited bright blue fluorescence at 442 
nm [165] as shown in Figure 3.7.  
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Figure 3.7: Excitation-emission spectra of AF350 [166]. 
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Derivatization of amines with FITC 
 
A 100 µL aliquot of an amine solution (1 mg/mL in methanol) is mixed with 12.7 µL of a 
FITC-solution (10 mg/mL in acetone) and 50 µL borate buffer (20 mM, pH 9.2). The 
reaction is performed for 2 h in the dark. The reaction of the FITC with an amine is shown 
in scheme 3.2. 
O OHO
N C S
COOH
R NH2
O OHO
COOH
NH
C
S
HNR
+
FITC
Analyte
FITC-analyte
Scheme 3.2: Analyte derivatization with FITC. 
 
Excitation-emission spectra of FITC 
 
FITC-dye is used for the derivatization of primary and secondary amines. Its 
excitation/emission wavelengths (488/520 nm) are shown in Figure 3.8. 
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Figure 3.8: Excitation-emission spectra of FITC [166]. 
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Derivatization of ephedrine and pseudoephedrine in tablets 
 
The commercially available tablets Asmoline (20 mg/tablet ephedrine) and 
Congestal  (60 mg/tablet pseudoephedrine) are used. One tablet of each drug is 
powdered and dissolved in methanol according to the declaration of the product to 
obtain 1 mg/mL stock solutions. Prior to derivatization, the extract is centrifuged and 
filtered through a 0.45 µm membrane filter. The remaining procedure is performed 
analogous to that described under the derivatization of amines with FITC. 
 
Derivatization of ephedrine and pseudoephedrine in human urine 
 
1 mL of human urine is diluted with 1 mL of water and 1 mL of 20 mM borate buffer 
pH 9. Ephedrine and pseudoephedrine reference compounds are dissolved in diluted 
urine to obtain 1 mg/mL stock solutions and the derivatization is completed as 
mentioned above. 
 
Standard diuretics stock solutions  
 
The stock solutions of diuretics are prepared to give the concentration of 0.2 mg/mL 
in methanol and stored at 4 oC. 
 
Stock solutions of diuretic tablets  
 
Hydikal, Epitens and Edemex tablets, containing 5 mg/tablet amiloride, 30 mg/tablet 
triamterene, and 1 mg/tablet bumetanide, respectively, are used. One tablet of each 
drug is powdered and dissolved in methanol according to the declaration of the 
product to obtain 0.2 mg/mL stock solutions.  
 
3.8 Chemicals 
 
2-Butylamine, 2-octylamine, (R)-(-)/(S)-(+)-1-cyclohexylethylamine, (-)-ephedrine, 
(+)-pseudoephedrine, HPMC and PVA (Mr 89000–98000) are obtained from Aldrich 
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(Steinheim, Germany). DMSO, FITC (isomer I), sodium hydroxide, 
sodiumtetraborate, sodium dihydrogen phosphate monohydrate, sulfuric acid, SDS 
and hydrogen peroxide are purchased from Fluka (Neu-Ulm, Germany). HPLC-grade 
acetone, methanol and ACN are obtained from Merck (Darmstadt, Germany). 
Amiloride, triamterene, BFMTZ, bumetanide CHES and MES are obtained from 
Sigma (Deisenhofen, Germany). Native cyclodextrins and hydroxypropyl-γ-
cyclodextrin (HP-γ-CD) are from Wacker (Burghausen, Germany). Metoprolol 
tartrate is kindly donated by Prof. J. Crommen (University of Liége, Belgium). Alexa 
Fluor® 350 carboxylic acid succinimidylester is obtained from Molecular Probes 
(Leiden, The Netherlands). Commercially available tablets of Hydikal® (5 mg/tablet 
amiloride), Epitens® (30 mg/tablet triamterene), Edemex® (1 mg/tablet bumetanide), 
Asmoline® (20 mg/tablet ephedrine) and Congestal ® (60 mg/tablet pseudoephedrine), 
are kindly donated by the National Organization for Drug Control and Research 
(NODCAR, Cairo, Egypt).  
 
3.9 MCE experiments 
 
After cleaning the chip using Piranha solution followed by the etching process as 
previously described (section 3.4), the respective BI, SI and SO holes are loaded with 
2 µL buffer solution. By applying a vacuum at the BO, the channels are completely 
filled after that 2 µL buffer solution is added to the BO. Then the SI is emptied and 
filled with 2 µL sample solution. After setting up the electrode plate, the sample is 
injected using pinched injection. This is achieved by a two-step high-voltage program. 
In the first step (injection mode), a sample plug is placed in the intersection and after 
15 s the voltage is switched to the separation mode, where a small sample plug is 
injected and the sample is separated. For a PVA-coated chip the polarity of the 
potentials are reversed. Between the runs, the coated/uncoated chips are rinsed with 
water and buffer for 30 s. 
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Chapter 4 Results and discussion 
 
4.1 Surface modification 
 
Currently, the lower resolution obtainable in powder blasted (pb) chips restricts the 
application of the fast and economic powder-blasting process for manufacturing 
fluidic devices for chip electrophoresis. Therefore, the numbers of publications that 
use pb-chips are very rare [134-138]. Recently, van den Berg et al. [10] reported that 
7–9 times lower plate numbers were obtained on a pb-chip compared to a wc-chip 
with similar dimensions. As the lower separation performance of pb-chips is 
attributed to the high surface roughness, this issue can be overcome by the application 
of immobilized polymer coatings to cover the channel surface. 
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Figure 4.1: Scanning electron microscope (SEM) micrographs (500 times zoomed) 
and corresponding surface profile scans of wc-(A) and pb-channels. The glass wafer 
was blasted with 9 µm large Al2O3-particles with 5.6 bar (B) and 4.0 bar (C) 
compressed air [10, 138]. 
Chapter 4 Results and discussion 44
As shown in Figure 4.1, scanning electron microscopy (SEM) images and data from 
Dektak measurements visualize the dimensions and surface roughness of the uncoated 
wet chemical etched (wc) and pb-chips [10, 153]. The surface of the wc-chips is very 
smooth (Figure 4.1A) while the surface roughness is noticeable for pb-chips (Figures 
4.1B,C). Comparing channels blasted with different air pressure, it can be observed 
that structures generated at lower pressure exhibit, as expected, smoother surfaces 
(Figure 4C). 
Recently, Belder et al described that immobilized poly(vinyl alcohol) (PVA) coatings 
can greatly improve the separation performance of classical wc-chips [167, 168]. 
Transferring this coating process to pb-chips can lead to a major achievement for the 
powder-blasting technique. Such devices would be especially attractive for the 
analyses of adsorptive proteins where hydrophilic coatings are essential to realize 
high-resolution free zone electrophoretic separations with glass chips [160].  
In this project, permanent PVA coatings as well as dynamic coatings are applied to 
pb-chips. The coated pb-chips are utilized in chip electrophoresis and the obtained 
data are compared to the results obtained from classical wc-chips.  
 
AF350-labeled amine test compounds 
 
To evaluate the correlation between increased surface roughness and the separation 
performance, the separation performance of the different labeled substrates in chip 
electrophoresis is examined. 
For this purpose, some anionic compounds are used in this study including       
AF350-metoprolol, AF350-dicyclohexylamine, AF350-α-4-dimethylbenzylamine and 
AF350-2-butylamine as shown in Figure 4.2.  
In the first stage of this work, the separation of the four labeled amines (Figure 4.2) is 
performed with a classical CE using 40 mM phosphate buffer at pH 6. The 
corresponding electropherogram is shown in Figure 4.3A.  
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Figure 4.2: Chemical structure of the AF350-amine test compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Electropherograms of the AF350-amine test compounds using 40 mM 
phosphate buffer at pH 6. Conditions: (A) Capillary, 50 cm effective, 70 cm total 
length, 50 µm i.d. Injection, 10 s hydrodynamic injection. Separation, 30 kV. 
Detection using Argos system at 360 nm exci/385 nm emis. (B) effective separation 
length, 3.4 cm; injection potentials, BI 1.06, BO 3.32, SI 1.22, SO 0.0 kV, separation 
potentials, BI 2.4, BO 0.0, SI 2.00, SO 2.00 kV Peak identification: (1) AF350- 
metoprolol, (2) 2- AF350-dicyclohexylamine, (3) AF350-α-4-dimethylbenzylamin, (4) 
AF350-2-butylamine, (5) originating from the fluorescent dye, 29 mM each in A and 
2.9 mM in B. 
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As shown in Figure 4.3A, the four labeled amine compounds are separated using an 
untreated fused silica capillary with a total separation length of 70 cm (50 cm to the 
detector) within 17 min. It is noted that the peak originated from AF350 dye is well 
resolved (peak 5) from the AF350-amines at 20 min. Afterwards, the separation is 
successfully performed on a 50 µm wet chemical etched chip as shown in Figure 
4.3B. As we can see from Figure 4.3, the migration time obtainable using MCE 
(separation within 102 s) is 11-times faster in comparison with CE system (separation 
within 1200s).  
Similar experiments are then performed using 100 µm wc-chips. It is observed that 
the 40 mM phosphate buffer led to a very high electrical current as 100 µm channels 
are used rather than the 50 µm ones. This results in a Joule heating which causes 
undesirable effects such as bubble formation and backflow from SI. As a 
consequence, a dye solution leakage and a baseline drift occur. The sample leakage 
can be monitored by a video microscopy during the measurement as shown in Figure 
4.4. For these reasons, the results do not provide an acceptable separation as shown in 
Figure 4.5.  
 
(A) sample loading (B) sample injected  
 
Figure 4.4: Video image of the leakage through the 100 µm channel. 
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Figure 4.5: Baseline drifts due to leakage through the 100 µm channel with an effective 
separation length of 4 cm and other conditions as in Figure 4.3B.  
 
 
 
 
In order to obtain stable conditions and reproducible results, a 10 mM phosphate 
buffer at pH 6 is used. Video images shown in Figure 4.6 reveal a successful pinched 
injection when 10 mM phosphate buffer at pH 6 is used (in both wc and pb chips). 
The corresponding electropherograms are shown in Figure 4.7.  
As depicted in Figure 4.7, the four compounds are not completely resolved. 
Therefore, only two test compounds are used rather than four in order to ensure 
complete peak resolution and reliable peak analyses which are important for 
consistent determination of plate numbers. For this purpose, peak 1 (AF350-
metoprolol) and peak 4 (AF350–2-butylamine) are chosen in the current study. The 
corresponding electropherograms using different chips (100 µm channels) are shown 
in Figure 4.8. 
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Figure 4.6: Video images of the injection process using uncoated 100 µm wc- and pb- 
chips. 
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Figure 4.7: Electropherograms of the AF350 labeled amines using uncoated 100 µm 
wc- and pb-chips, effective separation length, 4 cm. Other conditions and peak 
identification are as in Figure 4.3B. 
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As expected, AF350-metoprolol and AF350–2-butylamine compounds are well 
resolved in a 100 µm uncoated wc-chip (Figure 4.8A) with a resolution of 3.79 and 
separation efficiencies of N1= 24000, N2= 19000, respectively. These values are 
relatively high compared to the uncoated pb-chip (Figure 4.8C) which provides a 
resolution of 2.73 and separation efficiencies of N1= 5000, N2= 5000.  
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Figure 4.8: Efficiencies and resolutions of the separation of AF350-labeled amines 
using coated and uncoated wc- and pb-chips, respectively. In case of coated chips the 
polarity is reversed; peak identification: (1) AF350-metoprolol, (2) AF350–2 
butylamine, (3) originating from the fluorescent dye, 2.9 mM each. Effective 
separation length, 4 cm. Other conditions are as in Figure 4.3B. 
 
 
It is observed that the uncoated wc-chip provides a separation efficiency of almost 
4.5-times higher compared to results in an uncoated pb-chip (Figures 4.8A and C). 
This can be explained as the surface roughness of the pb-channel leads to a non 
uniform EOF, which leads to band broadening with the results of a reduced resolution 
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and separation efficiency. These values are in good agreement with the published 
reports on the limited separation performance of pb-chips [10, 149, 152].  
After the separation of AF350-labeled amines is performed on different uncoated chips, 
these chips are permanently coated using PVA [164]. This is applied in order to examine 
the improvement of the separation performance by covering the rough surface with an 
internal coating. For this purpose, the chips are slowly rinsed with a 3% aqueous solution of 
PVA. The adsorbed PVA layer is then dried in a nitrogen gas stream and immobilized by a 
heating step at 160 oC [164]. This procedure is performed twice in order ensure a complete 
coating efficiency. Afterwards, the separation of the AF350-labeled amines is checked 
using the prepared double coated chips. 
For the application of PVA coated chips, the polarity is reversed as the EOF is 
suppressed resulting in an anionic net mobility of the analytes and a reversed 
migration order (see Figures 4.8B and D). Comparing Figures 4.8A and B, the 
resolution in a wc-coated chip is enhanced form 3.79 to 6.68 and the dye signals are 
now well resolved. These results agree well with the published work utilizing 50 µm 
wc-chips [164], in which up to a 3-times increase in separation efficiency can be 
observed using PVA-coated chips for the analysis of fluorescently labeled amines. 
For a pb-coated chip, the resolution is also enhanced from 2.73 to 8.54 which is 
highly improved compared to the results of a coated wc-chip. Although the 
resolutions in wc- and pb-coated chips are improved, there is a diverse effect on the 
separation efficiencies. While the separation efficiencies of compounds 1 and 2 are 
reduced, a significant improvement in the separation efficiencies of the dye signals is 
observed (Figures 4.8B and D). This can be explained by the increased joule heating 
in 100 µm channels leading to an extra band broadening. As Joule heating is time-
dependent, the compounds that migrate slower will be more affected than the fast 
migrating ones. 
Finally, from Figures 4.8C and D it can be concluded that coating of pb-channels 
greatly improves the resolution, making coated pb-chips comparable to wc-devices. 
 
Effect of dynamic coating  
 
In order to examine if the improved separation performance found in devices coated 
permanently with PVA is also observed with uncoated pb-chips, dynamic coatings for 
EOF suppression such as hydroxypropylmethylcellulose (HPMC) and polyvinyl 
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alcohol (PVA) are applied. 
In this experiment, 1% PVA and 1% HPMC are prepared in warm deionized water 
then diluted with the running buffer with a ratio of 1:10 to obtain 0.1% solutions. The 
corresponding electropherograms are shown in Figure 4.9. It is surprising that PVA 
has no effect on the EOF suppression in pb-chips as shown in Figure 4.9A. The 
addition of HPMC resulted in a strongly reduced EOF (Figure 4.9B) and in similar 
migration patterns in comparison to the permanently PVA-coated pb-chip (Figure 
4.8D). The observed separation efficiency is, however, higher for the permanently 
PVA-coated device, indicating that covering the rough surface with a permanent layer 
of a hydrophilic polymer is more effective than dynamic coating. 
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Figure 4.9: Effect of dynamic coating on the separation of AF350-labeled amines 
using bare pb-chips. Buffer, 10 mM phosphate, pH 6 with 1% PVA or 1%HPMC, 
effective separation length, 4 cm; injection potentials, BI 1.1, BO 3.3, SI 1.2, SO 0.0 
kV, separation potentials, BI 2.4, BO 0.0, SI 2.0, SO 2.0 kV, in case of an HPMC-
modified buffer the polarity is reversed due to a suppressed EOF. Other conditions 
are as in Figure 4.3B. 
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FITC-labeled amine test compounds 
 
The results shown above indicate that the resolution of the labeled AF350-amines 
obtained in coated pb-chips is highly improved compared to results in coated wc-
chips. To confirm this, additional work is performed using FITC-amine test mixtures 
on different blasted microchips. Such test mixtures consist of FITC-metoprolol, FITC-
2-octylamine and FITC-2-butylamine as shown in Figure 4.10.  
O
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NH
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FITC-metoprolol FITC-2-octylamine
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Figure 4.10: Chemical structure of the FITC-amine test compounds. 
 
Here, different microchips involving pb (4 bar), pb (5.6 bar) and wc-chips are used. 
The corresponding electropherograms are shown in Figure 4.11. 
It is observed that partial separation of the test mixture is possible with both types of 
pb-chips utilizing a separation length of 7 cm, as shown in Figures 4.11A and B. The 
separation efficiencies, as well as the resolution, obtained in structures manufactured 
at high pressure are slightly lower to that obtained for channels blasted with lower 
pressure. In details, the FITC-amine compounds are partially resolved with a resolution of 
1.2 of the FITC-metoprolol and FITC-2-octylamine utilizing the uncoated pb-chip (4 bar) 
with a separation efficiency of 10000 (Figure 4.11A). Partial separation of FITC-labeled 
amines is also possible in an uncoated pb-chip (5.6 bar) with a separation efficiency and 
resolution values of 9000 and 1.1, respectively (Figure 4.11B). Errors for the determination 
of the separation efficiency as well as for the resolution are about 10% (n = 3). As a result, 
the differences in mean values of separation performance, N4bar = 10 000 to N5bar = 9000 
and resolution R4bar = 1.2 to R5.6bar = 1.1 are not significant [153]. 
Using the uncoated wc-chip, the three signals are well resolved and the plate number 
is with N = 36 000 about three times higher compared to that obtainable in pb-chips, 
as shown in Figure 4.11C. Also the resolution R of signal 1 and 2 is significantly 
improved from about R1,2 = 1.2 for pb-chips to R1,2 = 1.9. 
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Figure 4.11: Efficiencies and resolutions of separation of FITC-labeled amines using 
uncoated and coated wc- and pb-chips. In case of coated chips the polarity is 
reversed; Buffer, 40 mM CHES, pH 9.2; effective separation length, 7 cm; injection 
potentials, BI 1.35, BO 4.1, SI 1.5 SO 0.0 kV, separation potentials, BI 4.0, BO 0.0, SI 
3.4, SO 3.4 kV; peak identification: (1) FITC-metoprolol, (2) FITC-2-octylamine, (3) 
FITC-2-butylamine, 0.2 mM each. 
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These values are not surprising because the surface roughness of the wc-chips is in the nm-
range while it is in µm-range for pb chips. In addition, these results match well with the 
AF350-amines results in terms of lower resolution in pb-chips.  
After the separation of FITC-labeled amines is performed on different uncoated chips, these 
chips are permanently coated using PVA as described in the previous section. As the EOF 
is suppressed in PVA-coated chips, the anionic compounds have now to be detected at 
the anode by switching the polarity of the HV-source. The suppression of EOF results 
also in an increase of the migration time.  
The separation performance of the FITC-labeled amines is then checked using the prepared 
coated chips. With such coated chips, a significantly improved resolution of the pb-
chips of the test compounds is observed as shown in Figures 4.11A1 and B1. The 
resolution of the test compounds is significantly improved (R1,2= 2.6) which is even 
higher than the value obtained with the uncoated wc-chips (R1,2= 1.9). Although the 
resolution value obtained in coated pb-chips is 2-times higher than the uncoated ones 
(R1,2= 1.2), the separation efficiency is not improved significantly.   
Also with the coated wc-chips, an improved resolution with a value of 2.7 is observed 
(Figure 4.11C1). However, it is surprising that the separation efficiency in the coated 
wc-chips (Figure 4.11C1) is significantly lower compared to the respective uncoated 
chips (Figure 4.11C). This does not agree with the published work [164] where a 
significant increase in separation efficiencies with PVA-coated wc-chips is observed. 
Reasons for this are different experimental conditions such as larger channel 
dimensions with channel width of 100 µm in this work and 50 µm in the published 
work [164]. A comparison of the data of the PVA-coated wc-chip (Figure 4.11C1) 
with the coated pb-chips (Figures 4.11A1,B1) shows that wc-chips provide better 
separation performance, especially with regard to the separation efficiency, which is 
about 2-times higher.  
 
Chiral separation 
 
While the lower resolution of uncoated pb-chips might be acceptable for some 
applications it is especially problematic for more demanding applications like chiral 
separations. For this purpose, hydroxypropyl-γ-cyclodextrin (HP-γ-CD) is used as a 
chiral selector for the separations of FITC-labeled cyclohexylethlylamine 
enantiomers. When the chiral separation of enantiomers is performed in an uncoated 
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pb-chip it is found that the chiral compounds are resolved as a single peak (Figure 
4.12C) while they are partially resolved (R=0.9) in an uncoated wc-chip as shown in 
Figure 4.12A. Applying permanent PVA coating, the two enantiomers are well 
resolved in both coated wc- and pb-chips (Figures 4.12B, D). In a coated wc-chip, the 
enantiomers provide a resolution of 1.5 which is relatively higher compared to results 
in coated pb-chip (R=1.2). In addition, a relatively shorter migration time is obtained 
with the coated wc-chip. The separation time is 125 s while it is 156 s with the coated 
pb-chip. 
Concluding it can be said that the coated pb-chips are well suited in chiral separations 
although they provide a lower resolution compared to coated wc-chips. 
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Figure 4.12: Chiral separation of (R)2(2) and (S)2(2)-FITC-1-cyclohexylethylamine 
(0.2 mM each) using coated and uncoated wc- and pb-chips, respectively. Buffer, 
40mM CHES, 6.25mM HP-γ-CD, pH 9.2. Other conditions are as in Figure 4.11, 
except in the case of coated chips the polarity is reversed. 
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4.2 Application to drug analysis 
 
Currently, the need of a commercial instrument for drug analysis will support the 
emergence of microfluidics from pure research to application. This will ensure 
increasing acceptance of “chips” by clinical and forensic analytical communities, and 
hopefully encourage further exciting developments like those presented below. While 
a substantial effort has been expended in the development of clinical devices for 
point-of-care (POC) applications, much less attention has been developed to forensic 
applications. 
For this reason, on-a-chip methods for some abuse and therapeutic drugs will be 
described below. The application to pharmaceutical formulations and biological fluid 
are also studied. The linearity, reproducibility and applicability of those methods are 
then evaluated. Such methods can be used in clinical toxicology, therapeutic drug 
monitoring, forensic science and doping control. 
 
4.2.1 Application to central nervous system stimulant drugs 
 
It is well known that ephedrine and its diastereoisomer pseudoephedrine have 
stimulating effects [169-171] on the central nervous system (CNS). These compounds 
are not only accepted for medical purposes but also classified as drugs of abuse. 
Ephedrine and pseudoephedrine (Figure 4.13) are generally the most abundant 
alkaloids found in ephedra, and they typically constitute more than 80% of the 
alkaloid content of the dried plant material [172, 173]. 
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Figure 4.13: Chemical structure of (-)-ephedrine and (+)-pseudoephedrine. 
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Ephedrine is used as a sympathomimetic drug to treat asthma or bronchitis while 
pseudoephedrine is prescribed for symptoms of cold and flu including nasal 
congestion, cough, fever, and chills [174–177]. 
Concerns about the safety of ephedra-containing products have led to the 
development of a variety of analytical methods to assess their alkaloid content. For 
the quality control of ephedra herbs, high performance liquid chromatography 
(HPLC) is the most common analytical technique [178, 179]. However, this technique 
is a time-consuming analysis and needs relatively large amounts of sample. 
Recently studies indicated that capillary electrophoresis (CE) provides good results in 
the analysis of Chinese traditional herbal medicine [180-183]. Currently, several CE 
methods have been developed for the separation and determination of ephedrine and 
pseudoephedrine in ephedra herbs, formulations, foods and human urine [184-191]. 
In this section, an argon ion laser operating at 488 nm coupled with a microscope 
based chip electrophoresis system is used for sensitive detection of labeled ephedrine 
and pseudoephedrine drugs. Development and validation of a fast micellar 
electrokinetic capillary chromatography (MEKC) method on a chip is also described 
for the simultaneous determination of the two alkaloids in pharmaceutical 
formulations and human urine.  
 
4.2.1.1 Method development 
 
Derivatization of ephedrine and pseudoephedrine 
  
Most alkaloids that usually occur in plants are either weakly fluorescent or 
nonfluorescent compounds making trace analysis difficult without fluorogenic 
derivatization. In this study, since native fluorescence is insufficient for the detection 
of ephedrine and pseudoephedrine, more sensitive measurements are possible after a 
simple derivatization reaction. In this work, FITC is chosen to derivatize ephedrine 
and pseudoephedrine because of (i) its efficiency for the derivatization of secondary 
amines, (ii) the match of its excitation and emission wavelengths with a 488/520 nm 
argon ion laser optical system, and (iii) its high fluorescence quantum yield and 
molecular absorption coefficient [192]. 
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Effect of SDS concentration on the separation performance 
 
After derivatization of the two isomers, the selection of a suitable buffer is studied to 
achieve the best resolution, the highest sensitivity and the shortest analysis time. In 
the first stage of this work, the separation of the labeled ephedrine and 
pseudoephedrine is performed using a classical CE system with a buffer containing 10 
mM borate at pH 9.5. However, the results do not provide an acceptable separation as 
shown in Figure 4.14A. This may be attributed to the fact that all analytes migrate 
according to their mass-to-size ratios in CE, which are in this case very similar. For 
this reason, it is necessary to further improve the method using sodium dodecyl 
sulfate (SDS) with 10 mM borate at pH 9.5. For this purpose, the concentration of a 
SDS surfactant is varied from 0 to 50 mM within the method development. It is found 
that addition of 10 mM SDS to the buffer results in a complete resolution of the two 
compounds (Figure 4.14B). However, it is still not suited for chip separation because 
the shorter separation length of a chip format can lead to unacceptable separation and 
possible overlapping peaks. A higher concentration of SDS like 35 mM SDS results in 
an acceptable peak resolution (Figure 4.14C) which can be transferred to the MCE 
system. Higher concentrations of SDS, such as 50 mM, result in an unacceptable 
resolution as shown in Figure 4.14D. As the peak 2 and peak 3 shown in Figure 4.14D 
are very close, they are also not suited for chip measurements.  
 
 
 
 
 
 
 
 
 
 
Figure 4.14: Electropherograms of FITC labeled stimulant drugs obtained using 
classical CE system. Conditions: Capillary, 60 cm effective, 80 cm total length, 50 µm 
i.d. Injection, 2 s hydrodynamic injection. Separation, 30 kV. Detection using Argos 
system at 477 nm exci/495 nm emis. Compounds and concentrations: (1) 6.25 µg/mL 
FITC-ephedrine (2) 6.25 µg/mL FITC-pseudoephedrine. (3) FITC dye. 
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This is due to the fact that the separation channel in MCE has a fixed length of only 
several centimeters (up to 7 cm) while in classical CE the capillary length is flexible 
and long separation capillaries are usually used (60 cm in this case). 
Therefore, a 35 mM SDS solution added to 10 mM borate buffer at pH 9.5 is chosen as 
the optimal concentration that provides both good resolution and sensitive detection of 
the compounds. As shown in Figures 4.14B, C, D, the addition of SDS to the buffer 
enhances the resolution of the FITC-E, the FITC-PE and the FITC-dye as well. This is 
important especially in quantitative analysis to assure correct calculation of peak areas. 
This can be explained by the fact that the micelle phase (SDS) has mobility against the 
EOF. This results in an increase in the migration time of FITC-E and FITC-PE 
compounds with an increase in SDS concentration. In this case, the resolution can be 
enhanced by enlarging the effective migration distance of the analytes and as a result, 
increasing the mobility differences between FITC-E and FITC-PE.  
 
Effect of chip type  
 
After selection of the suitable buffer, the effect of the pb-chip compared to wc-chip on 
the separation performance of the two isomers is also examined within the method 
development. For this purpose, three different glass chips are utilized such as 100 µm 
pb, 100 µm wc and 50 µm wc-chips as well as fused silica (FS) chips. The separation 
of the two drugs is successfully performed using such chips with the previously 
selected buffer. The corresponding electropherograms are shown in Figures 4.15, 
4.16. As described before, the pb-chips provide lower resolution due to their surface 
roughness. The influence of the surface roughness is shown by the separation of 
labeled ephedrine and pseudoephedrine on a pb-chip which results in a low resolution 
value of 1.5 (Figure 4.15A). This value is comparable with that obtained using a 100 
µm wc-chip (Figure 4.15C). 
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Figure 4.15: Electropherograms of FITC labeled stimulant drugs obtained in 
different chips. Conditions: BGE is 10 mM borate buffer at pH 9.5+35 mM SDS. 
Effective separation length, 2 cm. Injection potentials, BI 0.65, BO 2.050, SI 0.75, and 
SO 0.00 (kV); separation potentials, BI 2.00, BO 0.00, SI and SO 0.7 (kV). 
Compounds and concentrations: (1) 1.2 µg/mL FITC-ephedrine (2) 1.2 µg/mL FITC-
pseudoephedrine. Mercury lamp at 450-480 nm is used as excitation light source. 
 
 
 
The 50 µm wc-chip seems to be well suited in this study in terms of better resolution 
(R=2.5) and lower current value (I= 32 µA) as shown in Figure 4.15B. As a result, the 
lower electric current value leads to low electrical conductivity allowing to work at 
high field strengths without typical problems in chip separations due to Joule heating. 
In addition, by using a FS-chip an improvement in the separation efficiency by a 
factor of two is achieved. Also, a faster separation time (within 40 s) is observed 
compared to borofloat (BF) chips (within 55 s) as shown in Figure 4.16. The higher 
separation efficiency obtained in a FS-chip may be attributed to the effect of Joule 
heating. As Joule heating is time-dependent, the compounds that migrate slower 
(Figure 4.16A) will be more affected than the fast migrating ones (Figure 4.16B). 
Both microchips are used in the current study, however, a FS-chip is more favorable 
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because it has good transmittance and low autofluorescence properties in the deep UV 
spectral region. 
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Figure 4.16: Electropherograms of FITC labeled stimulant drugs obtained in a BF-
chip (A) and a FS-chip (B). Conditions: BGE is 10 mM borate buffer at pH 9.5+35 
mM SDS. Effective separation length, 5 cm Injection potentials, BI 0.65, BO 2.050, SI 
0.75, and SO 0.00 (kV); separation potentials, BI 4.00, BO 0.00, SI and SO 3.4 (kV). 
Other conditions and peak identification are as in Figure 4.15.  
 
 
Effect of SDS on sensitivity and efficiency 
 
SDS similarly, as any anionic species, does not interact with the negatively charged 
surface of the channels, which is favorable especially in chip measurements. MEKC 
in a chip format is not applied very often and uses micelles only for controlling the 
selectivity and the migration of analytes. The solubilization of the analyte in the 
micellar phase alters its properties significantly [127]. On this account, additional 
work is performed to study the effect of SDS on the sensitivity and peak efficiency, 
for example addition of SDS to the buffer can improve the sensitivity and separation 
efficiency. In Figure 4.17, FITC-E is used for these measurements, in which the S/N 
ratio is improved by a factor of 4 after addition of SDS to the buffer. This is due to the 
fact that in different applications SDS is reported to be a good fluorescence enhancer 
[193, 194], which is caused by the higher viscosity inside the micelles compared to 
the outside environment. Increased viscosity restricts the relaxational motion of 
molecules and thus enhances the fluorescence yield [194]. Improvement in the 
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separation efficiency by a factor of 6 is achieved as well. It can be concluded that 
MEKC is the method of choice in this study because it has the benefit of a higher 
sensitivity compared with the CZE method (Figure 4.17A).  
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Figure 4.17: Electropherograms of 1.2 µg/mL FITC-ephedrine: (A) in 10 mM borate 
buffer at pH 9.5 on a BF chip, (B) in 10 mM borate buffer at pH 9.5+35 mM SDS on 
a BF chip and other conditions are as in Figure 4.16.  
 
 
Effect of the light source 
 
As described previously (section 3.2.3), the setup of the MCE system can be coupled 
with different light sources allowing different applications. For this purpose, an 
epifluorescence setup is used enabling the coupling of an argon-ion laser into a 
commercial fluorescence microscope. The detection of the analytes is performed by 
laser-induced fluorescence (LIF) using an argon ion laser with an excitation 
wavelength of 488 nm (with an emission filter at 520 nm) in comparison to lamp 
based fluorescence detection at 450-480 nm (with an emission filter >515 nm). It is 
found that LIF detection provided a 40-fold higher sensitivity in relation to a lamp 
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based fluorescence detection. As shown in Figure 4.18, the LOD of the standard 
compounds is determined to be 140 pg/mL using an argon ion laser while it is at 6 
ng/mL using a mercury lamp. Nevertheless, both detection methods are used for the 
sensitive determination of the two alkaloids in formulations and human urine. 
Argon ion laser at 488 nm Mercury lamp at 450-480 nm 
1 
2 
 
 
Figure 4.18: Electropherograms of standard ephedrine and pseudoephedrine at the 
limit of detection: (A) 6 ng/mL FITC-ephedrine (peak 1) and 6 ng/mL FITC-
pseudoephedrine (peak 2) on a FS-chip using mercury lamp detection, (B) 140 pg/mL 
FITC-ephedrine (peak 1) and 140 pg/mL FITC-pseudoephedrine (peak 2) on a FS-
chip using argon ion laser, other conditions are as in Figure 4.16. 
 
 
4.2.1.2 Application to pharmaceutical formulations 
 
Fast determination of the active ingredient in a drug is very useful in the manufacture 
and quality control of medicines. In order to quantify the amount of ephedrine and 
pseudoephedrine in commercial tablets, the previously developed MCE methods are 
validated with regard to precision, linearity, LOD, LOQ and accuracy.  
For the determination of calibration plots, standard samples of labeled ephedrine and 
pseudoephedrine at eight different concentration levels are prepared covering the 
range from 0.5-4000 ng/mL of each labeled compound. Each sample is analyzed three 
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times and the mean peak areas are calculated. 
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Figure 4.19: Standard calibration plots for standard ephedrine and pseudoephedrine: 
(A) using mercury lamp on a BF-chip, (B) using argon ion laser on a FS-chip and 
other conditions are as in Figure 4.16. 
 
 
Calibration lines are obtained by plotting the concentration on the abscissa versus the 
mean peak area. The resultant calibration plots exhibit good linearity as shown in 
Figure 4.19. The regression parameters which are calculated from the calibration 
curves are reported in Table 4.1. As seen in Table 4.1, calibration curves of ephedrine 
and pseudoephedrine provide good correlation coefficients (r2>0.990 for both 
compounds) ensuring a linear response over the concentrations range. 
The limit of detection (LOD) is defined as the analyte concentration which leads to an 
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S/N ratio of 3:1. These values are measured for both drugs to either be 6 ng/mL by 
using the mercury lamp or 0.14 ng/mL using the argon ion laser for excitation. The 
corresponding electropherograms are shown in Figure 4.18. The limit of 
quantification (LOQ) is defined as the analyte concentration that can be analyzed with 
acceptable precision and accuracy usually determined from a series of diluted 
solutions exhibiting an S/N≥10. The typical LOQ values for both drugs are 
determined on one hand at 0.6 µg/mL with the mercury lamp or on the other hand at 
0.5 ng/mL with the argon ion laser, as shown in Figure 4.20. All values of LOD and 
LOQ are listed in Table 4.1. 
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Figure 4.20: Electropherograms of standard ephedrine and pseudoephedrine at 
LOQ: (A) 0.6 µg/mL FITC-E (peak 1) and 0.6 µg/mL FITC-pseudoephedrine (peak 2) 
on a BF-chip using mercury lamp detection, (B) 0.5 ng/mL FITC-ephedrine (peak 1) 
and 0.5 ng/mL FITC-pseudoephedrine (peak 2) on a FS-chip using argon ion laser, 
other conditions are as in Figure 4.16. 
 
 
The intraday accuracy and precision of the method are determined by running three 
replicates of the standard (3.6 µg/mL of E, PE or 2 ng/mL E, PE using either mercury 
lamp or argon ion laser, respectively). The measurement with each FITC-derivatized 
drug shows high reproducibility in terms of peak areas and migration times. The 
relative standard deviation (RSD) is a statistical term to measure the precision for a 
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series of repetitive measurements. For this reason the RSDs of the peak areas (Table 
4.1) are calculated to be less than 3% or less than 2% for migration time revealing that 
the method is highly precise.  
 
Table 4.1: Method validation for quantitative determination of ephedrine and         
pseudoephedrine (* n= 3 measurements). 
 
 
Mercury lamp at 480 nm Argon ion laser at 488 nm  
Ephedrine Pseudoephedrine Ephedrine Pseudoephedrine
Linearity 0.6-4 µg/mL 0.6-4 µg/mL 0.5-10 ng/mL 0.5-10 ng/mL 
LOD 6 ng/mL 6 ng/mL 0.14 ng/mL 0.14 ng/mL 
LOQ 0.6 µg/mL 0.6 µg/mL 0.5 ng/mL 0.5 ng/mL 
RSD% peak 
area* 
2.35 2.55 1.96 1.50 
RSD% migration 
time* 
0.79 1.85 1.44 1.82 
Correlation 
coefficient 
0.9978  0.9902 0.9987 0.9994 
Intercept - 48883 -115511 - 16247 - 10582 
Slope 417031 985449 326454 339993 
Parameter 
 
 
The validated MCE methods are then applied to the commercially available tablets 
containing ephedrine and pseudoephedrine such as Asmoline (20 mg/tablet ephedrine) 
and Congestal (60 mg/tablet pseudoephedrine) tablets. The tablets are powdered and 
dissolved in methanol using an ultrasonic bath for 20 min. The resulting solutions are 
filtered and diluted to give stock solutions with concentrations of 1 mg/mL for each 
drug under examination. After labeling with FITC, the obtained electropherograms of 
the tablets are shown in Figure 4.21. The results reveal that the larger amounts of 
excipients, generally used in tablets, do not interfere with the drugs under 
investigation. As depicted in Figure 4.21, it is obvious that the resultant peaks are well 
resolved without interfering by-products. Furthermore, no shifts in migration time 
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relative to pure ephedrine and pseudoephedrine standards are observed. 
The applicability of the methods for determination of ephedrine and pseudoephedrine 
in tablets is carried out using the standard addition technique as a check for accuracy.  
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Figure 4.21: Electropherograms of ephedrine and pseudoephedrine in commercial 
tablets: (A) Asmoline tablets: 1.2 µg/mL FITC-ephedrine and Congestal tablets: 1.2 
µg/mL FITC-pseudoephedrine on a BF-chip using mercury lamp, (B) Asmoline 
tablets: 5 ng/mL FITC-ephedrine and Congestal tablets: 5 ng/mL FITC-
pseudoephedrine on a FS-chip using argon ion laser. Other conditions are as in 
Figure 4.16. 
 
For this purpose, four different amounts of the standard solutions are added to 
solutions of the tablets, and then the recovery of each drug in tablets is calculated. The 
produced results are reproducible with low relative standard deviations (RSDs) as 
shown in Table 4.2. The values of average recovery of ephedrine and 
pseudoephedrine in formulations are about 100.69 and 100.49%, respectively (see 
Table 4.2). RSD, (is an indicator of precision) of the mean recoveries is less than 4%. 
The average amount of ephedrine and pseudoephedrine in tablets is calculated to be 
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20.13 and 60.29 mg/tablet respectively. Such results are described in details in Table 
4.2. The results obtained for the content of E and PE in the pharmaceutical 
formulations are in good agreement with the labeled amount in tablets. This indicates 
that the method is robust and can be employed as a routine method for quality control 
of ephedrine and pseudoephedrine dosage forms. 
 
Table 4.2: Determination of ephedrine and pseudoephedrine in pharmaceutical 
formulations (n= 4 measurements).  
Formulation Amount of 
standard added 
Amount of 
standard found 
Recovery % Light source 
1.20 µg/mL 1.19 µg/mL 99.17 
1.80 µg/mL 1.85 µg/mL 102.78 
2.40 µg/mL 2.44 µg/mL 101.67 
 
Asmoline tablets 
(20 mg/tablet E) 
3 µg/mL 3.02 µg/mL  100.67 
Mean 
recovery% 
  101.05 
RSD%   1.51 
1.20 µg/mL 1.17 µg/mL 97.50 
1.80 µg/mL 1.85 µg/mL 102.78 
2.40 µg/mL 2.36 µg/mL 98.33 
 
Congestal tablets 
(60 mg/tablet PE) 
3 µg/mL 3.14 µg/mL  104.67 
Mean 
recovery% 
  100.82 
RSD%   3.42 
 
 
 
 
 
Mercury lamp 
1 ng/mL 0.98 ng/mL 98 
2 ng/mL 2 ng/mL 100 
3 ng/mL 3.1 ng/mL 103.33 
 
Asmoline tablets 
(20 mg/tablet E) 
4 ng/mL 4 ng/mL 100 
Mean 
recovery% 
  100.33 
RSD%   2.21 
1 ng/mL 0.99 ng/mL 99 
2 ng/mL 1.95 ng/mL 97.50 
3 ng/mL 3.05 ng/mL 101.67 
 
Congestal tablets 
(60 mg/tablet PE) 
4 ng/mL 4.1 ng/mL 102.50 
Mean 
recovery% 
  100.17 
RSD%   2.32 
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Chapter 4 Results and discussion 69
4.2.1.3 Application to human urine 
 
With the development of modern sports games and the increasing number of doping 
cases, it is demanding to develop fast and highly sensitive screening methods for 
doping control. In 1990, the Medical Commission of the International Olympic 
Committee included the ephedrine and pseudoephedrine in the list of forbidden 
substances [69]. Recently, the commission has adopted the following limits of 
concentration in urine above which an athlete is considered to be ‘‘positive’’: 25 
µg/mL for pseudoephedrine and 10 µg/mL for ephedrine. Antidoping controls are 
routinely carried out on the urine and thus a fast, simple and reliable analytical 
method is needed for identifying the abuse of such compounds by athletes. 
However, analysis of drugs in body fluids using microfluidic devices presents a 
special challenge, both in terms of sensitivity and fouling of microchannels by matrix 
components. In addition the derivatization of the compounds in pure urine without 
extraction is a problematic issue due to inhibition of the derivatization process by 
endogenous urine components. The dilution of urine with water (1:1) and a concurrent 
alkalinization with basic buffer can solve this problem. Several other methods have 
been described in the literature for the determination of ephedrine in urine [195-197]. 
However, there are no available techniques for the determination of ephedrine or 
pseudoephedrine without extraction. The previously developed MCE methods can be 
also used for quantitative determination of both drugs in human urine. 
 
In vitro analysis 
 
 For in vitro analysis, ephedrine and pseudoephedrine with known concentrations in 
urine are derivatized as previously described (section 3.7). The calibration plots are 
performed within the concentration ranges 2-4200 ng/mL for each compound. As 
shown in Figure 4.22, the calibration plots exhibited good linearity. The linearity of 
the calibration curves provides correlation coefficient values higher than 0.995 as 
shown in Table 4.3. RSD of peak area (n= 3) is calculated to be less than 4%. All 
regression parameters and RSD values are listed in Table 4.3. 
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(A) Mercury lamp 
Pseudoephedrine Ephedrine 800 
 1600 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22: Standard calibration plots for ephedrine and pseudoephedrine in human 
urine: (A) using mercury lamp on a BF-chip, (B) using argon ion laser on a FS-chip 
and other conditions are as in Figure 4.16. 
 
 
 
Table 4.3: Determination of ephedrine and pseudoephedrine in human urine (* n= 3). 
 
Mercury lamp at 480 nm Argon ion laser at 488 nm  
Ephedrine Pseudoephedrine Ephedrine Pseudoephedrine
Linearity 0.6-4.2 µg/mL 0.6-4.2 µg/mL 2-10 ng/mL 2-10 ng/mL 
LOD 20 ng/mL 120 ng/mL 0.5 ng/mL 1 ng/mL 
LOQ 0.6 µg/mL 0.6 µg/mL 2 ng/mL 2 ng/mL 
RSD% peak area* 2.60 3.25 2.16 2.85 
Correlation 
coefficient 
0.9984 0.9970 0.9960 0.9991 
Intercept 6068 1936 - 13299 - 3789 
Slope 370244 170443 131141 69224 
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The corresponding electropherogram for in vitro analysis is shown in Figure 4.23. 
Using the mercury lamp (Figure 4.23A), the two stimulant drugs are completely 
resolved, however, peak broadening is observed which is expected due to the high 
ionic strength of the urine. Using an argon ion laser, Figure 4.23B, the two 
compounds are resolved providing very sharp peaks which are well resolved from the 
endogenous urine components.  
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Figure 4.23: Electropherograms of FITC-ephedrine and FITC-pseudoephedrine in 
vitro human urine: (A) 1.2 µg/mL FITC-ephedrine and 1.2 µg/mL FITC-
pseudoephedrine on a BF-chip using mercury lamp or (B) 10 ng/mL FITC-ephedrine 
and 10 ng/mL FITC-pseudoephedrine on a FS-chip using argon ion laser. Other 
conditions are as in Figure 4.16. 
 
 
Due to the fact that the urine background is different from the water background, 
many amino-containing substrates in urine will compete in the derivatization and the 
labeling efficiency may not be as high as in pure water. Therefore, LODs are 
determined in urine by using a mercury lamp to be 20 and 120 ng/mL for E and PE, 
respectively, as shown in Figure 4.24A (6 ng/mL in aqueous solution). All values of 
LODs in urine are reported in Table 4.3. 
Using argon ion laser, very low concentrations of E and PE in urine are measured to 
be 0.5 and 1 ng/mL, respectively, as shown in Figure 4.24B. These data reveal that 
LIF utilizing an argon ion laser is the best approach for sensitive detection of 
ephedrine and pseudoephedrine in urine. The practical detection limits are lower than 
expected and fulfill the requirements for stimulants screening with a threshold of 10 
µg/mL.  
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Figure 4.24: Electropherograms of standard ephedrine and pseudoephedrine in 
human urine at the limit of detection: (A) 20 ng/mL FITC-ephedrine and 120 ng/mL 
FITC-pseudoephedrine on a BF-chip using mercury lamp, (B) 0.5 ng/mL FITC-
ephedrine and 1 ng/mL FITC-pseudoephedrine on a FS-chip using argon ion laser. 
Other conditions are as in Figure 4.16. 
 
 
In vivo analysis 
 
For in vivo analysis, the assay described under in vitro analysis is applied to urine 
samples collected from human volunteers after oral intake (after 12h) of 20 mg 
ephedrine and 60 mg pseudoephedrine. It is well known that 70-80% of ephedrine and 
pseudoephedrine dose is excreted unmetabolized in the urine within 48 hours [188-
191]. According to the calibration curves and the associated regression equations, the 
unknown concentrations in patient urine are calculated to be 0.6 µg/mL and 0.9 
µg/mL for ephedrine and pseudoephedrine, respectively. Figures 4.25A and B 
represent the typical electropherograms obtained with the human urine where the 
migration time remains unchanged whilst peak separation is still satisfactory.  
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Figure 4.25: Electropherograms of FITC-ephedrine and FITC-pseudoephedrine 
(A,B) in vitro human urine on a BF-chip using mercury lamp (C) FITC-urine blank. 
Other conditions are as in Figure 4.16. 
 
For in vivo analysis, small peaks of the stimulants are detected as shown in Figures 
4.25A and B. This is attributed to the fact that drugs in biological fluid are present at 
low concentration levels because of metabolic processes or the low therapeutic doses 
of the drugs. For FITC-E, only a small peak of the drug is observed at 42 s which is 
well resolved from the peak originating from the dye as shown in Figure 4.25A. On 
the other hand two small endogenous peaks are observed in case of FITC-PE (Figure 
4.25B), however, they do not interfere. The electropherogram obtained from the 
analysis of the blank urine spiked with FITC is shown in Figure 4.25C which 
demonstrates that no major endogenous components are detected in the time range of 
the drugs of interest. Therefore, direct urine analysis is feasible without significant 
sample treatment. Furthermore, the obtained MCE results can be considered to be 
more sensitive compared to those obtained by CZE [197] or by solid phase micro-
extraction method [195]. 
It can be concluded that the developed MCE-fluorescence methods provide several 
advantages over conventional chromatography methods. The analysis time using 
MCE is usually within several seconds in contrast to GC or HPLC, where the analysis 
time is usually 30-60 min. In MCE measurements, only a few µL of aqueous buffer 
are employed, showing that the method is economic and environmentally friendlier. 
Furthermore, with the use of fluorescence detection, a small amount of analytes in 
Chapter 4 Results and discussion 74
microchip can be determined with high sensitivity. Based on these advantages, 
microchip analysis is well suited for doping control as well as in pharmaceutical labs. 
 
4.2.2 Application to diuretic drugs 
 
Diuretics are a heterogeneous group of compounds widely used in the treatment of 
congestive heart failure and hypertension [198]. Diuretics have been misused in sports in 
recent years, for two reasons: (1) athletes may wish to reduce their body weight quickly in 
order to qualify for a lower mass class (2) athletes may wish to dilute their urine to avoid 
a positive doping result [198]. Diuretics are classified according to their chemical 
structure, their mechanism and site of action within the nephron, and their diuretic 
potency. They are classified as thiazides (e.g., bendroflumethiazide), loop diuretics (e.g., 
bumetanide), potassium sparing diuretics (e.g., amiloride and triamterene) [198]. The 
chemical structures of the four diuretics under investigation are shown in Figure 4.26.  
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Figure 4.26: Chemical structure of the diuretic drugs. 
 
In literature, several chromatography methods such as HPLC [199, 200], GC [201, 
202], and TLC [203, 204] have been reported for the separation, detection, and 
determination of diuretics. Among these methods, RP HPLC with UV-detection is the 
most common one and has been adapted as the standard screening method for doping 
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control. In recent years, CE methods for diuretics analysis have been developed 
applying CZE [205, 206] or MEKC [207, 208]. 
In this section, development and validation of a fast MCE method is introduced for 
the simultaneous determination of unlabeled diuretic drugs in pharmaceutical 
formulations and human urine. 
 
4.2.2.1 Method development 
 
Native fluorescence of diuretics 
 
In the first part of this section, in order to optimize the detection setup, the excitation-
emission wavelengths of the diuretics are determined using fluorescence spectroscopy 
as shown in Figure 4.27. 
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Figure 4.27: 3-D measurements of the excitation-emission spectra of the diuretic drugs under 
analysis: (A) 1 µg/mL Amiloride in MES pH 5.5, (B) 0.08 µg/mL Triamterene in MES pH 5.5, 
(C) 1 µg/mL BFMTZ in MES pH 5.5, (D) 1 µg/mL Bumetanide in MES pH 5.5. 
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In these experiments, 0.2 mg/mL diuretic standard solutions are used. A series of diluted 
solutions in MES buffer at pH 5.5 is then prepared that include 1 µg/mL amiloride, 0.08 
µg/mL triamterene, 1 µg/mL BFMTZ, and 1 µg/mL bumetanide. The corresponding 
excitation-emission spectra shown in Figure 4.26 reveal that the four diuretics under 
examination provided native fluorescence which can be measured using CE or MCE with 
different fluorescence excitation light sources. 
 
Effect of pH on the separation performance 
 
The separation of the four diuretics is performed with a classical capillary electrophoresis 
instrument using a previously described 15 mM borate buffer at pH 8 [206]. Separation of the 
diuretics is performed in the mode of CZE which has the benefit of simplicity and rapid 
analysis for charged compounds. The separation is performed on a chip within 15 s (Figure 
4.28B) rather than 7 min using a classical CE system (Figure 4.28A). This makes MCE an 
attractive alternative to CE, especially when fast separations are required.  
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Figure 4.28: Comparison of electropherograms of standard diuretic compounds obtained with 
classical CE (A) and MCE (B) in 15 mM borate buffer pH 8. Conditions: (A): Capillary, 60 cm 
effective, 80 cm total length, 50 µm i.d. Injection, 10 kV, 5 s. Separation, 30 kV. Fluorescence 
detection using an Argos 250B Detector, excitation at 325 nm, emission light collected with a 
high pass filter at 385 nm. Compounds and concentrations: (1) 25 µg/mL amiloride, (2) 2 
µg/mL triamterene, (3) 25 µg/mL bendrofluomethiazide, and (4) 25 µg/mL bumetanide. 
Conditions: (B): Effective separation length, 2 cm. Injection potentials, BI 1.35, BO 4.10, SI 
1.50, and SO 0.00 (kV); separation potentials, BI 4.00, BO 0.00, SI and SO 3.2 (kV). 
Compounds and concentrations: (1) 5 µg/mL amiloride, (2) 1 µg/mL triamterene, (3) 15 µg/mL 
bendrofluomethiazide, and (4) 5 µg/mL bumetanide. Detection using HeCd laser at 325 nm. 
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In Figure 4.28, the same buffer system is used but with analytes concentration of 5 
times lower for on-chip separations (e.g. 5 µg/mL for amiloride). This is due to the 
fact that a HeCd laser is utilized as excitation source while a commercial lamp based 
fluorescence detection system is used in classical CE.  
In order to improve the detection sensitivity and electrophoretic resolution, different 
buffer systems at different pHs and ionic strengths are studied. In electrophoresis, the 
pH of the buffer medium affects the electrophoretic mobility which modifies the 
migration velocity, separation efficiency and detection sensitivity [206]. For the drugs 
of interest, the effect of pH is studied in the pH range from 3-7 with Na-phosphate 
buffer, at pH 8 with borate buffer and at pH 9 with CHES buffer. The corresponding 
electropherograms are shown in Figure 4.29. 
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Figure 4.29: Electropherograms of diuretics using different pH buffers. Conditions 
and peak identification are as in Figure 4.28B. 
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For the drugs under examination, a decrease in pH results in an increase in migration 
time (Figure 4.29A). This observation agrees well with the fact that the electro-
osmotic mobility in capillaries has a sigmoid relationship with the pH [206, 209, 210]. 
At pH 3, the four compounds are separated within 42 s providing a low S/N ratio. At 
pH 4 (Figure 4.29B), the compounds are partially resolved within 24 s along with an 
enhancement in sensitivity (S/N=112 for triamterene while it is 70 at pH 3). At pH 5 
(Figure 4.29C), the compounds are well resolved within 18 s with a S/N ratio of 113 
for triamterene which is comparable with those obtained at pH 4. Using MES buffer 
at pH 5.5 (Figure 4.29D), it is found that the S/N ratios of all diuretics are highly 
improved by a factor of about two (206 for triamterene) compared to their values at 
pH 5 and a fast separation is also obtained (14 s). At pH 6, the compounds provide 
better resolution but a lower sensitivity (Figure 4.29E). In the pH range from 7-9 
(Figures 4.29F,G,H), the compounds are partially resolved and they do not provide a 
complete baseline separation, especially at pH 9. 
The migration order of the diuretics is shown to be related to the molecular structure 
and the mass of the drugs (see Figure 4.25). Diuretics containing amine groups such 
as amiloride and triamterene are present as cations in acidic pH buffers. Respective 
acidic buffers are however less suited for diuretics containing carboxylic or 
sulphonamide groups such as bendroflumethiazide and bumetanide.  
 
Effect of additives and organic solvents 
 
Also additives like native cyclodextrins and SDS are studied within the method 
development. It is found that the addition of SDS does not improve the separation 
sensitivity as expected but results in longer migration times (108 or 30 s) as shown in 
Figures 4.30A and B. Addition of native α, β and γ-cyclodextrins results in faster 
separation time, however, they do not improve the sensitivity and resolution. In these 
experiments, it is found that the four diuretics are not resolved completely in case of β 
or γ-cyclodextrin (Figures 4.30F and G) while a complete resolution is obtained with 
the addition of α-cyclodextrin (Figure 4.30E). Dimethyl sulfoxide (DMSO) and 
acetonitrile (ACN) as solvents are also studied; however, the compounds do not 
provide acceptable baseline separation using these solvents (Figures 4.30C and D). 
Finally a 5 mM MES buffer at pH 5.5 is chosen as an optimal buffer providing both, 
good resolution and sensitive detection of the compounds (Figure 4.29D). 
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Furthermore the selection of a MES buffer is advantageous because of the relatively 
low electrical conductivity, allowing to work at high field strengths without typical 
problems in chip separations due to Joule heating. 
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Figure 4.30: Electropherograms of diuretics using some additives to the buffer 
system. Conditions and peak identification are as in Figure 4.28B. 
 
 
 
Effect of the light source 
 
After adjusting the buffer system, different lasers besides lamb based fluorescence 
detection are used to enhance the detection limit of the diuretics. For the analysis of 
diuretics, the performance of the detection sensitivity is compared using either a 
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mercury lamp (330-380 nm exc. with an emission filter >420 nm), a HeCd laser (325 
nm exc. with an emission filter >350 nm) or a pulsed frequency doubled Nd:YAG-
laser (266 nm exc. with an emission filter > 320 nm). A comparison of different 
electropherograms obtained is shown in Figure 4.31.  
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Figure 4.31: Comparison of sensitivities obtained with different light sources for 
excitation in MCE, Buffer, 5 mM MES, pH 5.5. Other conditions and peak 
identification are as in Figure 4. 28B.  
 
 
As shown in Figure 4.31, different electropherograms are obtained using different 
light sources due to the different spectral properties of the analytes (see Figure 4.27). 
Using a lamp based fluorescence detection (Figure 4.31B) the sensitivity of amiloride 
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is improved by a factor of two and by a factor of four for triamterene compared to the 
HeCd laser (Figure 4.31A). This is not surprising due to the fact that their excitation 
wavelengths (360 nm) fit well to the excitation wavelength of the filter (330-380 nm) 
which is used in the instrumental setup. Although the two compounds are excited at 
the same wavelength (see Figure 4.27), the triamterene compound provides a higher 
fluorescence quantum yield than amiloride. This can explain why the sensitivity of 
triamterene using the mercury lamp is much better than amiloride. The four 
compounds are completely detected using a HeCd laser (Figure 4.31A) in comparison 
with the mercury lamp with an improvement in the sensitivity of BFMTZ by a factor 
of eighteen and by a factor of four for bumetanide. Detection of all compounds can 
also be performed utilizing a 266 nm Nd:YAG-laser with lower sensitivity for all 
compounds as in Figure 4.31C.  
LIF utilizing a HeCd laser is the best approach for sensitive detection of diuretics for 
the current application.  
 
4.2.2.2 Quantitative analysis of diuretics in tablets 
 
The developed MCE method is then applied to the pharmaceutical preparations after 
validation. To validate this method, first, the calibration curves for the standard 
compounds are determined covering the concentration ranges of 1-20 µg/mL 
amiloride, 50-1000 ng/mL triamterene, 1-20 µg/mL bendroflumethiazide and 2-20 
µg/mL bumetanide. At least eight concentration levels are examined. For each level, 
four measurements are taken and the average peak area is used to make the calibration 
curve. The obtained calibration plots shown in Figures 4.32 exhibit a good linearity 
with the correlation coefficients of 0.9965, 0.9959, 0.9962, and 0.9969 for amiloride, 
triamterene, BFMTZ and bumetanide, respectively. The other regression parameters 
involving slopes and intercepts of the obtained calibration curves are listed in Table 
4.4. The statistical data reported in Table 4.4, reveal a good linearity and precision. 
Intra-day relative standard deviations (RSD) are calculated (n=4) in Table 4.4 for the 
peak area and migration time. In all cases, the RSD values are less than 2 % for peak 
area and 3 % for migration time.  
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Figure 4.32: Standard calibration plots for standard diuretic drugs using HeCd laser 
and other conditions are as in Figure 4.28B. 
 
 
 
Table 4.4: Method validation for quantitative determination of diuretic drugs (* n= 4). 
Parameters Amiloride Triamterene BFMTZ Bumetanide 
Sensitivity range 1-20 µg/mL 50-1000 ng/mL 1-20 µg/mL 2-20 µg/mL 
LOQ 1 µg/mL 50 ng/mL 1 µg/mL 2 µg/mL 
LOD 250 ng/mL 12.5 ng/mL 300 ng/mL 900 ng/mL 
RSD% peak area* 1.85 1.61 1.02 1.11 
RSD% migration time* 1.66 1.94 1.23 2.30 
Correlation coefficient 0.9965 0.9959 0.9962 0.9969 
Intercept 23752 28449 25482 -7949 
Slope 85793 1544 62549 58797 
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The limits of detection (LOD) are given in Table 4.4. These values are confirmed by 
injection of a standard solution close to the LODs, resulting in a peak height for all 
diuretics which is equal to or less than three times of the baseline noise. The 
corresponding electropherograms are shown in Figure 4.33. 
As described above, the HeCd laser provides better sensitivities for amiloride and 
triamterene. As a result, LODs for amiloride and triamterene are determined to be 250 
ng/mL and 12.5 ng/mL, respectively (Figures 4.33A and B). It is observed that, the 
measured LOD of triamterene is twenty times better than amiloride. This means that 
the proposed method is highly sensitive for quantitative determination of triamterene 
comparing with amiloride. It is also observed that less sensitivities are obtained for 
BMFTZ and bumetanide, whose LODs are determined to be 300 ng/mL and 900 
ng/mL, respectively (Figures 4.33C and D). 
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Figure 4.33: Electropherograms of standard diuretics at the limit of detection: (A) 250 
ng/mL amiloride, (B) 12.5 ng/mL triamterene, (C) 300 ng/mL bendroflumethiazide, (D) 
0.9 µg/mL bumetanide, and other conditions are as in Figure 4.28B. 
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The limits of quantitation (LOQ) are calculated from a series of diluted solutions 
exhibiting an S/N≈10. These values are determined to be 1 µg/mL amiloride, 50 
ng/mL triamterene, 1 µg/mL BFMTZ and 2 µg/mL bumetanid as shown in Figure 
4.34.   
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Figure 4.34: Electropherograms of standard diuretics at LOQ. (A) 250 ng/mL 
amiloride, (B) 12.5 ng/mL triamterene, (C) 300 ng/mL BFMTZ, (D) 900 ng/mL 
bumetanide. Other conditions are as in Figure 4.28B. 
 
 
 
The validated method is then applied to the commercially available tablets such as 
Hydikal (5 mg/tablet amiloride and 50 mg/tablet HCTZ), Epitens (30 mg/tablet 
triamterene and 10 mg/tablet xipamide) and Edemex tablets (1 mg/tablet bumetanide). 
The tablets are finely powdered, dissolved in methanol and then diluted to give stock 
solutions with concentrations of 0.2 mg/mL according to the labeled amount of the 
drug. Afterwards, all solutions are filtered before being introduced into the chip in 
order to avoid any contaminations from the tablets coating materials. The 
corresponding electropherograms obtained for each tablet are shown in Figure 4.35. 
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In the electropherogram representing the hydikal tablets (Figure 4.35A), the peak of 
amiloride is well resolved from the other compound, HCTZ, without interfering. In 
electropherograms of Epitens and Edemex tablets (Figures 4.35B and C) only the 
respective signals of triamterene and bumetanide are obtained. Currently, the 
formulations containing BFMTZ is not available in the market. The interday 
reproducibility of migration times, as evident from the comparison of respective 
migration times in Figures 4.33–4.35, is poorer as expected due to fluctuations in EOF 
and ambient temperatures. 
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Figure 4.35: Electropherograms of the diuretics in commercial tablets: (A) Hydikal 
tablet: 10 µg/mL amiloride, (B) Epitens tablet: 250 ng/mL triamterene, (C) Edemex 
tablet: 10 µg/mL bumetanide. Other conditions are as in Figure 4.28B. 
 
Quantitative determination of the diuretics in tablets is performed using the standard 
addition technique as described in Table 4.5. For this purpose, four different amounts of 
each standard are added to the solutions of the pharmaceutical formulations. Each MCE-
experiment for quantitation is repeated four times. The values of the average recovery for 
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diuretics in formulation ranged from 99.96 to 100.74 % indicating the reproducibility of 
the method with relative standard deviations less than 2%. The amount of drugs is 
calculated in tablets to be 5.01, 30.22 and 0.99 mg/tablet for amiloride, triamterene and 
bumetanide, respectively. Theses results are in good agreement with the labeled amount 
of diuretics in formulations as described in Table 4.5. These data show that chip 
electrophoresis is well suited for quantitative determination of drugs in formulations 
within seconds.  
 
Table 4.5: Determination of diuretics in pharmaceutical formulations (n=4). 
Formulation Amount of 
standard added 
Amount of standard 
found 
Recovery % 
5 µg/mL 5.02 µg/mL 100.40 
7 µg/mL 6.90 µg/mL 98.75 
9 µg/mL 9.13 µg/mL 101.44 
Hydikal tablets 
(5 mg/tablet amiloride) 
11 µg/mL 11.10 µg/mL 100.90 
Mean recovery%   100.32 
RSD%   1.24 
200 ng/mL 198.06 ng/mL 99.03 
300 ng/mL 303.36 ng/mL 101.12 
400 ng/mL 408 ng/mL 102 
Epitens tablets 
(30 mg/tablet 
triamterene) 
500 ng/mL 504 ng/mL 100.80 
Mean recovery%   100.74 
RSD%   1.25 
4 µg/mL 4.10 µg/mL 102.50 
6 µg/mL 5.90 µg/mL 98.33 
8 µg/mL 8 µg/mL 100 
Edemex tablets  
(1 mg/tablet 
bumetanide). 
10 µg/mL 9.90 µg/mL 99 
Mean recovery%   99.96 
RSD%   1.83 
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4.2.2.3 Analysis of diuretics in human urine  
 
As described above, diuretics are used illegally by athletes to avoid detection of 
banned substances by reducing their concentration in urine. For this reason, the 
Medical Commission of the International Olympic Committee added diuretics to the 
banned substance list in April 1986, and they scheduled within a doping class from 
the 1988 Olympic Games [69, 209]. Recently, the World Anti-doping Agency 
(WADA), in its 2005 version, has included diuretics in the prohibited substances 
[211]. 
Many techniques have been developed for doping analysis such as automated solid 
phase extraction [212], HPLC [213] and recently capillary zone electrophoresis (CZE) 
[214-217]. However most of these techniques are time-consuming. Most of diuretics 
are excreted unchanged in urine [200]; therefore, the screening method for diuretics in 
human urine can be mainly developed to detect the native compounds (unmetabolized 
form). 
For this purpose, the developed MCE method can also be applied to the analysis of 
the diuretics dissolved in human urine. The elctropherogram in Figure 4.36A 
corresponds to the drug standards dissolved in human urine after dilution with water 
(1:1) to avoid the matrix effect.  
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Figure 4.36: (A) Electropherogram of the standard diuretic drugs in human urine (1) 
5 µg/mL amiloride, (2) 1 µg/mL triamterene, (3) 15 µg/mL bendrofluomethiazide, (4) 
5 µg/mL bumetanide, and (*) peak originated from endogenous urine components, (B) 
Electropherogram of the urine blank. Detection using mercury lamp at 330-380 nm, 
other conditions are as in Figure 4.28B.  
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In comparison with the electropherogram of the drug standard dissolved in running 
buffer (Figure 4.31B), the migration time remains unchanged and the separation is 
still satisfactory. The only significant difference is that the peaks are broadened when 
dissolved in urine which is expected due to the high ionic strength of the urine. In 
Figure 4.36B, the electropherogram of the blank urine is shown for comparison. No 
interferences from endogenous urine components are observed. 
In comparison with the GC-MS technique [218], which is commonly used in doping 
analysis, the developed MCE achieves a very fast separation (within 18 s), while in 
GC-MS the separation is achieved within minutes. However, the later method was 
used in the Sydney 2000 Olympic Games to analyze 3000 samples in 4 weeks [217] 
which is relatively slow and time consuming comparing to the developed MCE 
method. These results show that MCE can be used as a faster analytical principle for 
screening and confirmatory analysis in doping control. In addition, the advantage of 
detecting native fluorescence is the elimination of derivatization steps simplifying the 
proposed method and reducing the time of the total analysis. As a result, the 
introduced method shows good promise for applying it to the detection of trace levels 
of abused drugs in forensic analysis.   
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Chapter 5 Summary and conclusions 
 
The aim of this work was: 
1- Improvement of the performance of powder-blasted (pb) microchips by applying 
polyvinyl alcohol (PVA) as a permanent coating.    
It was found that the limited electrophoretic resolution obtained in powder-blasted 
(pb) chips could significantly be improved by coating the channels with polyvinyl 
alcohol. The performance of coated and uncoated powder-blasted (pb) devices as well 
as coated and uncoated wet chemical etched (wc) chips was compared in 
electrophoretic separations of fluorescently labeled test compounds. 
It was found that the uncoated powder-blasted chips provided lower theoretical plate 
numbers and poorer resolutions. Applying the coating process to powder-blasted 
chips, the resolution of test compounds in such coated powder-blasted devices was 
higher than in uncoated wet chemical etched chips.  
Dynamic coating of powder-blasted chips was also applied using hydroxy- 
propylmethylcellulose (HPMC) and polyvinyl alcohol. The latter was found to be not 
effective for dynamic coating while hydroxypropylmethylcellulose resulted in a 
strongly reduced EOF.  
PVA-coated pb-chips could also be applied in chiral separations. In an uncoated pb-
chip with a hydroxypropyl-γ-cyclodextrin (HP-γ-CD) buffer, only one broad signal 
was obtained while two well-resolved signals were obtained in a coated device. 
It can be concluded that, coated powder-blasted chips can become an economic 
alternative to wet chemical etched chips for many applications, especially in protein 
separations. 
2- Development and validation of fast methods based on microchip capillary 
electrophoresis (MCE) to determine some therapeutic and abuse drugs in formulations 
and human urine. Drugs such as central nervous system stimulants (ephedrine and 
pseudoephedrine) and diuretics were successfully determined using MCE. A fast 
micellar electrokinetic capillary chromatography (MEKC) method was introduced for 
the determination of FITC-labeled ephedrine and pseudoephedrine. Different light 
sources were used for excitation such as an argon ion laser and a mercury lamp. It was 
found that LIF utilizing an argon ion laser is the best approach for sensitive detection 
of ephedrine and pseudoephedrine in comparison to a mercury lamp. The method was 
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successfully applied to the analysis of the respective drugs in pharmaceutical 
formulations and human urine. 
Furthermore, a fast MCE method was developed for the determination of diuretics in 
formulations and human urine. Different light sources were used utilizing either a 
mercury lamp (330-380 nm), a HeCd laser (325 nm) or a pulsed frequency doubled 
Nd:YAG-laser (266 nm). The HeCd was chosen as an excitation light source which 
provided a higher sensitivity for the detection of the diuretics. The developed MCE 
method was successfully applied to formulations and human urine without 
interference from other active ingredients. 
It can be concluded that, MCE-separations of drugs are completed within seconds 
rather than several minutes as in HPLC. Furthermore as a chip electrophoresis can be 
integrated into portable analytical devices, this approach appears to be especially 
attractive for field analysis and point of care diagnostics.  
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